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ABSTRACT
Self-report questionnaires are used in clinical practice to aid in the process of
conceptualizing, diagnosing, planning treatment, and monitoring progress throughout
treatment. However, self-report questionnaires can be inconvenient to both clinicians and
patients if excessive time is needed to complete and score them. To date, a brief and
consolidated self-report questionnaire that measures anxiety, depression, anger,
suicidality, homicidality, positive mental health, and functioning does not exist. The
primary objective of this study was to evaluate the factor structure and the psychometric
properties of the self-report questionnaire, the Weekly Emotional and Functional
Summary (WEFS). The study was correlational, using archival data from 153 participants
receiving mental health treatment in northeastern Pennsylvania. A principal components
factor analysis was conducted to validate the proposed factor structure. Then,
standardized measures were used to compare to the WEFS factors. Correlational models
were also conducted to assess the stability of the scale over time and to examine the
relationship between the factors of the WEFS and other standardized measures in the
respective areas. Outcomes indicated that the WEFS is comprised of seven distinct
factors (i.e., three across the frequency domain, three across the intensity domain, and
one in the functioning domain) and exhibits construct validity, internal consistency, and
test-retest reliability. These results suggest that the WEFS demonstrates clinical utility.

Keywords: self-report questionnaire, test construction, principal components factor
analysis, construct validity, internal consistency, test-retest reliability
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CHAPTER 1: INTRODUCTION
Statement of the Problem
Self-report questionnaires are used in clinical practice to aid in collaboration
(Hatcher, 1999; Prescott et al., 2017; Simon et al., 2013), inform treatment (Wolfe &
Pincus, 1999; Zimmerman et al., 2008; Zimmerman et al., 2018), measure progress
outcomes (Goodheart et al., 2006; Hooke et al., 2018; Prescott et al., 2017), and increase
the efficacy of treatment (Zimmerman et al., 2008; Zimmerman et al., 2018). When
clinicians regularly gather feedback to evaluate progress outcomes, they can assess
whether the treatment goals are being met (Goodheart et al., 2006; Hooke et al., 2018;
Prescott et al., 2017). Valid data from a self-report questionnaire provide insight into
patients’ perceptions of their current levels of functioning and improvement over time.
Self-report questionnaires also provide another way for the patient to communicate with
the clinician, when speaking about concerns may be uncomfortable or challenging at first.
Patients value collaboration and appreciate the opportunity to share their feedback
with clinical practitioners (Hatcher, 1999; Prescott et al., 2017; Simon et al., 2013; Wolfe
& Pincus, 1999). Eliciting feedback also helps clinicians incorporate data from another
source to supplement their clinical impressions and ensure quality of care by confirming
that they are not overlooking problematic areas. As these measures produce quantitative
data, they are also used by insurance companies to gauge the efficacy of treatment when
evaluating coverage for patients (Nezu et al., 2000). Self-report questionnaires are
efficient, systematic, standardized (Wolfe & Pincus, 1999), and cost effective (Garfield et
al., 2011).
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The amount of time self-report questionnaires take to administer can be a
deterrent to regular use in clinical practice. To date, most self-report measures in clinical
practice are unidimensional, meaning that they measure only one facet of
symptomatology. Some self-report questionnaires, such as the Depression, Anxiety, and
Stress Scale (DASS; Lovibond & Lovibond, 1995), measure two facets. However, a
consolidated self-report questionnaire that measures frequency and severity of a variety
of symptoms, levels of positive mental health, functioning, and suicidality does not yet
exist in the field of psychology for outpatient mental health settings. This need is growing
in clinical practice because administering numerous self-report measures to assess mental
health symptoms and overall functioning is not time efficient and may be exhausting for
patients. However, administering a brief questionnaire that encompasses important
aspects of several measures would be informative while saving time for therapeutic
interventions in session.
The self-report questionnaire in study, the Weekly Emotional and Functional
Summary (WEFS), measures anxiety, depression, anger, risk, positive mental health, and
overall functioning. These factors were intentionally added to the WEFS because of their
relevancy in clinical practice. Specifically, anxiety was chosen as a factor in the measure
because it is one of the most prevalent psychological disorders, with one in four
individuals experiencing anxiety (Antony et al., 2001; Kessler et al., 1994). Anxiety is
not only highly prevalent, but also often undiagnosed and therefore untreated (Antony et
al., 2001; Weiller et al., 1998). Depression has been called the “common cold” of
psychological disorders because of its prevalence and significance (Nezu et al., 2000).
The World Health Organization (WHO) estimates that more than 300 million people will
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be diagnosed with depression at some point in their lives (WHO, 2018). Anger was also
included, as it is a common symptom indicative of emotional distress (Cella et al., 2010).
Suicidality and homicidality should be routinely assessed for the patient’s and the
public’s safety, a duty of mental health professionals (American Psychiatric Association
[APA] Ethics Code Standard 4.05b, 2002, Disclosures).
A patient’s overall functioning is crucial to measure as well, as it provides
information about the severity and level of impairment of the presenting problem. The
WEFS also measures positive mental health, an aspect of care that is not commonly
assessed in routine care (Trompetter et al., 2017).
Alleviating psychopathology has commonly been misunderstood as an automatic
increase in positive mental health (Greenspoon & Saklofske, 2001). However, according
to the dual-factor model, positive mental health and psychopathology symptoms are
related, but ultimately independent (Lukat et al., 2016; Trompetter et al., 2017). Positive
mental health is essential to measure and foster because it has been shown to aid in
problem-solving abilities, resilience (Frederickson, 2013), processing adversity (Tugade
& Frederickson, 2004), and regulating negative emotions (Teismann et al., 2018).
Measuring positive mental health is the first step in helping patients to grow beyond
psychopathology toward leading a fulfilling life.
The WEFS accounts for positive mental health, an important but commonly
missed aspect of care. If shown to be valid, this measure would be beneficial to the
clinical setting because it is brief and consolidates a variety of common symptoms and
presenting concerns while also assessing the impact of symptoms by measuring
functioning and positive mental health.
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Purpose of the Study
The purpose of the proposed archival study was to explore the psychometric
properties of the WEFS, an all-encompassing and consolidated scale for use with
psychiatric populations, developed by Dr. Jesus Salas. The variables of the WEFS that
were measured are as follows: anxiety, depression, anger, risk, positive mental health,
and overall functioning. A principal component factor analysis was conducted to examine
and validate the proposed factor structure. The validity of the WEFS was assessed by
studying the relationship between the WEFS and standardized measures with strong
psychometric properties, such as the Beck Anxiety Inventory (BAI), the Quick Inventory
of Depressive Symptomatology – Self Report (QIDS-SR), and the Clinical Outcomes in
Routine Evaluation- Outcome Measure (CORE-OM). The reliability of the WEFS also
was assessed by retesting patients 1 week after the time of intake. This quantitative study
used correlational methods, including construct validity, convergent validity, and testretest reliability, to determine the psychometric properties of the WEFS self-report
measure for use in clinical settings.. If the measure is shown to be valid and reliable, it
can be used in outpatient mental health settings as a valuable tool to help clients feel
understood and listened to, to aid in collaboration, to inform treatment, and to measure
progress over time.
Research Questions and Hypotheses
Does the Weekly Emotional and Functional Summary (WEFS), developed by
Jesus Salas, accurately measure anxiety, depression, anger, risk, positive mental health,
and overall functioning in psychiatric populations? Does the WEFS exhibit strong
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psychometric properties, such as construct validity, internal consistency, and test-retest
reliability?
Hypothesis 1
It is hypothesized that the items of the WEFS will cluster together to create
factors that measure anxiety, depression, anger, risk, positive mental health, and
functioning, as shown through a principle component factor analysis.
Hypothesis 2
To assess for convergent validity, it is hypothesized that the WEFS will be
correlated with standardized measures in each of the six factors.
(a) The WEFS’s anxiety factor will be negatively correlated with standardized
self-report measures of anxiety, including the Beck Anxiety Inventory (BAI) and
the PROMIS Emotional Distress Anxiety, Short Form, and positively correlated
with the negative affect subscale of the Positive Affect and Negative Affect
Schedule (PANAS).
(b) The WEFS’s depression factor will be positively correlated with standardized
self-report measures of depression, including the Quick Inventory of Depressive
Symptomatology, Self-Report (QIDS-SR); the PROMIS Severity Measure for
Depression, Adult; and the negative affect subscale of the PANAS.
(c) The WEFS’s anger factor will be positively correlated with a standardized
self-report measure of anger, including the PROMIS Emotional Distress Anger,
Short Form, and the negative affect subscale of the PANAS.
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(d) The WEFS’s risk factor will be positively correlated with a standardized selfreport measure of risk, including the risk dimension of the Clinical Outcomes in
Routine Evaluation – Outcome Measure (CORE-OM).
(e) The WEFS’s positive mental health factor will be positively correlated with a
standardized self-report measure of positive mental health, including the wellbeing dimension of the CORE-OM, and with the positive affect subscale of the
PANAS.
(f) The WEFS’s functioning factor will be negatively correlated with a
standardized self-report measure of functioning, including the functioning
dimension of the CORE-OM.
Hypothesis 3
It is also hypothesized that the WEFS will display test-retest reliability after a 1week retest period, further demonstrating the psychometric properties of the measure for
use in clinical settings.
Overall Rationale
A consolidated, yet brief, self-report measure would aid in collaboration, inform
treatment, measure progress outcomes, increase the efficacy of treatment, and improve
efficiency. If shown to be valid and reliable, the WEFS is hypothesized to enhance these
aspects of care through routine use in clinical settings.
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CHAPTER 2: REVIEW OF THE LITERATURE
Self-Report Measures
Self-report measures are the most common type of psychological measures that
assess narrowly defined characteristics of functioning (Kazdin, 2003). Self-report
measures evaluate actions and private experiences, such as psychological
symptomatology. They tend to be more face valid and transient, rather than obscure and
indirect. The format of self-report measures can vary, including true-false, multiplechoice, fill-in, and rating scales (Kazdin, 2003). Owing to the multifaceted nature of
clinical problems, self-report measures were not developed as the sole measurement for
diagnostic purposes. Rather, they were intended to complement other diagnostic tools and
clinical impressions to diagnose and monitor progress.
Purpose of Self-Report Measures
When conceptualizing, diagnosing, planning treatment, and monitoring progress,
clinicians use various sources of data to gather a comprehensive understanding of each
patient. These valuable sources of data include clinical tools clinicians review regarding
their understanding of the case, as well as measures the patient completes, such as selfreport measures. Accurately measuring psychological symptomatology leads to
purposeful and targeted treatment. The integration of reliable and valid clinical tools can
improve the accuracy of diagnosing and inform treatment, further increasing efficacy
(Bar-Kalifa et al., 2016; Hannan et al., 2005; Wolfe & Pincus, 1999; Zimmerman et al.,
2018).
Self-report measures offer unique, quantitative data. Gathering information from
patients in this way not only aids in the measurement of symptoms, but also enhances the
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therapeutic alliance by valuing the patient’s involvement (Wolfe & Pincus, 1999). Selfreport data come directly from the source and are quantifiable measurements of progress
outcomes (Lambert et al., 2001; Lambert et al., 2002; Lambert, Hansen, & Finch, 2001;
Nezu et al., 2000; Prescott et al., 2017; Wolfe & Pincus, 1999; Zimmerman et al., 2008;
Zimmerman et al., 2018). Self-report questionnaires provide clinicians with data that
cannot be gathered from another source (Wolfe & Pincus, 1999), as patients know best
how they are feeling. These measures are also valued because they help provide
clinicians with information to assess whether patients are meeting their goals in therapy.
Treatment protocols recommend the use of self-report questionnaires to measure
progress during the course of treatment (APA, 2010; Harding et al., 2011; National
Collaborating Centre for Mental Health, 2009; Trivedi et al., 2006; Zimmerman et al.,
2018). Routine outcome monitoring is now recognized by evidence-based practices as a
beneficial tool in treatment (Peterson & Fagan, 2017). In fact, routine outcome
monitoring has been shown to improve therapeutic outcomes by recognizing and
addressing patients who are not progressing through therapy, as patients do not improve
at the same rate (Goodheart et al., 2006; Peterson & Fagan, 2017). Identifying patients
who are not on track during therapy can help a clinician to understand or prompt patients
for clarification to determine why they are not progressing or to evaluate what is
inhibiting them from meeting their treatment goals (Simon et al., 2013).
Assessing progress outcomes throughout the therapy process can benefit patients
and assist in meeting treatment goals by providing clinicians with quantifiable data that
allow them to determine whether patients are deteriorating in therapy or staying on track
(Goodheart et al., 2006; Hooke et al., 2018). Bar-Kalifa et al. (2016) and Hannan et al.
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(2005) noticed that therapists were not as accurate in predicting patients who were
deteriorating in therapy without the use of quantitative data. Being able to measure and
understand obstacles to treatment through the information gathered on a self-report
questionnaire saves time in session to address these challenges and modify treatment
(Zimmerman et al., 2018).
Self-report questionnaires provide a standardized measure of quantitative data
(Lambert et al., 2001; Lambert et al., 2002; Lambert, Hansen, & Finch, 2001; Nezu et al.,
2000; Prescott et al., 2017; Wolfe & Pincus, 1999; Zimmerman et al., 2008; Zimmerman
et al., 2018). Other healthcare professionals, such as physicians, measure patient progress
through quantitative methods with blood pressure, weight, and heart rate. Quantitative
measures can also be applied to clinical practice when measuring symptoms, functioning,
and even positive mental health (Zimmerman et al., 2008). For example, gathering only
qualitative data in session by asking, “How have you been lately?” can lead to inaccurate
and subjective judgments of progress (Zimmerman et al., 2018). Quantitative measures
not only provide a baseline for functioning, but also demonstrate improvement over time
in a standardized way. Providing quantitative data allows for an appropriate comparison
to previous levels of functioning that qualitative data cannot offer with as much precision
(Lambert et al., 2001; Lambert et al., 2002; Lambert, Hansen, & Finch, 2001; Nezu et al.,
2000; Prescott et al., 2017; Wolfe & Pincus, 1999; Zimmerman et al., 2008; Zimmerman
et al., 2018).
The use of self-report measures in routine clinical practice minimizes clinician
bias andreduces the possibility of missing information and of underestimating the
severity of symptoms (Wolfe & Pincus, 1999; Zimmerman et al., 2018). Providing

WEEKLY EMOTIONAL AND FUNCTIONAL SUMMARY

11

quantifiable measurements directly from the source minimizes clinician bias, resulting in
more accurate depictions of the patients’ perceptions of their symptoms and current levels
of functioning. Incorporating this additional source of information can assist clinicians in
developing a comprehensive case conceptualization.
Specific questions on self-report measures relating to symptomatology and overall
functioning aid in information recalled by the patient and can reduce the chances of
missing details about which the patient may not have previously thought (Stone et al.,
1999). Fayers and Machin (2013) analyzed meta-analyses on clinician ratings and patient
ratings in relation to progress outcomes and found that the two ratings differed most of
the time. In fact, the clinicians in the study tended to overestimate or underestimate their
patients’ quality of life specifically (Fayers & Machin, 2013). Assessing data from the
patient and integrating them with the clinician’s diagnostic impression offer more
precision when diagnosing and planning treatment. Data from the patient can
complement the other diagnostic tools. Self-report measures were not intended to replace
clinical interviews or diagnostic protocols, but rather to be integrated to provide a holistic
view of the patient from multiple sources (Wolfe & Pincus, 1999).
Self-report questionnaires are also advantageous to clinical practice because they
are time efficient, costeffective (Weissman & Bothwell, 1976; Wolfe & Pincus, 1999;
Zimmerman et al., 2008; Zimmerman et al., 2018), and provide a standardized way to
demonstrate progress to insurance companies (Zimmerman et al., 2018). Patients can
complete the self-report questionnaire in the waiting room prior to an appointment,
saving time in session for interventions (Zimmerman et al., 2018). However, self-report
measures should be brief to not overwhelm and exhaust the patient (Zimmerman et al.,
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2008). Self-report measures provide a wealth of information at low cost as well
(Weissman & Bothwell, 1976; Wolfe & Pincus, 1999; Zimmerman et al., 2008;
Zimmerman et al., 2018). Many patients use insurance companies as a way to cover
mental healthcare. Insurance companies may require feedback regarding a patient’s
progress throughout treatment as evidence for the need of coverage. Self-report measures
can provide insurance companies with clear, standardized, and quantitative measurements
of progress (Nezu et al., 2000; Zimmerman et al., 2018).
Gathering a comprehensive understanding of a patient’s case informs and
increases the efficacy of treatment (Goodheart et al., 2006; Wolfe & Pincus, 1999;
Zimmerman et al., 2008; Zimmerman et al., 2018). Gathering detailed updates of
symptomatology from session to session can inform treatment and enhance therapy
outcomes (Zimmerman et al., 2008). Simply asking generic questions or eliciting a vague
update on the patient’s level of depression, for example, does not yield as detailed a
response as would asking specific questions regarding symptomatology,especially for
patients with chronic mental health conditions for which they may not notice small
improvements initially. Assessing detailed progress from week to week regarding mental
disorder symptoms and positive mental health can help the clinician to tailor treatment to
meet the patient’s unique needs and goals, thereby increasing efficacy (Goodheart et al.,
2006; Hooke et al., 2018; Zimmerman et al., 2008). Collaborating on the various steps of
treatment can aid in the efficacy of treatment and empower patients to take a vital role in
their progress (Wolfe & Pincus, 1999).
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Issues with Self-Report Questionnaires
Using self-report questionnaires in clinical settings to gather progress outcomes
and to monitor treatment can be useful to clinicians (Hooke et al., 2018). However,
common issues need to be considered when constructing and administering self-report
questionnaires. These measures take time to administer and score (Peterson & Fagan,
2017), they can provide inaccurate data as a result of distortions (Kazdin, 2003; Stone et
al., 1999), and responses can vary and be influenced by the wording and ordering of
items (Kazdin, 2003).
The Weekly Emotional and Functional Summary (WEFS) seeks to address the
critique that self-report questionnaires are too time consuming. Requiring patients to
complete various self-report measures to gather data on multiple variables likely would
be time consuming and regarded as an inconvenience. The WEFS offers a time-efficient
solution by assessing multiple variables in one brief, consolidated measure that is also
easy to score. Implementing routine use of the WEFS can provide the previously stated
benefits while decreasing the likelihood of patients becoming exhausted by completing
only one measure versus multiple measures each session. Additionally, the WEFS can be
completed in the waiting room prior to the patient’s appointment, as it is easy to
administer and understand. Completing a single parsimonious measure reduces the
patient’s exhaustion and complaints regarding completing multiple forms every week and
saves time in session for therapeutic interventions (Zimmerman et al., 2018).
Another issue of self-report measures to consider is that they do not provide
accurate data because patients tend to report based on either desiring to make themselves
appear better than they are or on overreporting to appear worse than they are (Kazdin,
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2003; Kline, 2015; Stone et al., 1999). Depending on patients’ motives, they may respond
in line with social desirability, be inconsistent with their responses, report what may not
be true, or exaggerate their responses (Kazdin, 2003). Some patients present to therapy
with a need for approval, so they may try to respond in ways that are consistent with what
they believe their clinicians would like to see. Social desirability in administering selfreport questionnaires can be expressed by acquiescence in true-false items. On the other
hand, some patients may be mistrustful initially and endorse items in the middle to guard
their true feelings.
To address this issue, patients may not accurately portray their current state of
mental health. However, patients underreporting or overreporting may still be considered
diagnostically relevant. For example, what function does underreporting or overreporting
serve for patients? How can patients’ perceptions of their symptoms in relation to
clinicians’ impressions be addressed in therapy? Clinicians can incorporate their
diagnostic impressions and clinical skills to the patients’ perceptions to address if the
patients are accurately reporting or to hypothesize why they may not be.
Self-report measures may generate inconsistent results because of wording,
format, or ordering of items (Kazdin, 2003). Patients may misunderstand the wording of
an item. Also, the format in which items are presented can influence responses, such as
the tendency to endorse “true” to items regardless of content as a way of attempting to
agree with the clinician. Although the impact in which items are ordered has not been
extensively studied, Kazdin (2003) recommended that standardized measures be
organized in a consistent way such that subscales and domains follow a structured and
coherent pattern.
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Despite these issues properly used self-report measures can offer a valuable
source of information to clinicians (Wolfe & Pincus, 1999; Zimmerman et al., 2018).
Self-report questionnaires complement data gathered to create a comprehensive
diagnostic picture by providing another source of information that is quantitative and
standardized (Lambert et al., 2001; Lambert et al., 2002; Lambert, Hansen, & Finch,
2001; Nezu et al., 2000; Prescott et al., 2017; Wolfe & Pincus, 1999; Zimmerman et al.,
2008; Zimmerman et al., 2018). Self-report measures were not created to replace clinical
skills and diagnostic impressions; rather, they were created to aid in diagnosing and
informing treatment (Kazdin, 2003; Stone et al., 2000; Wolfe & Pincus, 1999). Offering
this valuable source of information allows clinicians to understand the patients’ views of
their current state of mental health and then to incorporate those views with the
clinicians’ diagnostic impressions (Stone et al., 2000; Wolfe & Pincus, 1999).
Studies have compared clinician ratings and patient ratings on self-report
questionnaires and revealed that they differed at times. The clinicians in one study tended
to overestimate or in some cases underestimate their patients’ quality of life (Fayers &
Machin, 2013). Although clinicians differing with their patients regarding the severity of
the patients’ problems may not always occur, these findings suggest that eliciting
patients’ subjective views is still valuable because patients know themselves best (Stone
et al., 1999; Wolfe & Pincus, 1999).
Self-Report Measures to Date
Currently, self-report questionnaires tend to be unidimensional, meaning that they
measure one variable, or bidimensional, meaning that they measure two variables, such
as the Depression, Anxiety, and Stress Scale (DASS; Lovibond & Lovibond, 1995).
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Although these various self-report questionnaires are valid, reliable, and useful for
clinical settings, they do not address the criticism of self-report questionnaires taking too
much time to administer.
Peterson and Fagan (2017) surveyed clinicians to better understand why they
were not using self-report measures, despite the vast array of research supporting their
use. Clinicians frequently reported that they did not want to burden their patients each
week (Peterson & Fagan, 2017). Self-report measures burdening patients would be
understandable if patients were asked to complete multiple measures or long measures
each week. The development of a consolidated and brief measure would address this
concern in clinical practice.
Many self-report questionnaires to date do not measure both the intensity and the
frequency of symptomatology. Rather, many measures assess either the severity of
symptoms or the frequency with which each symptom occurs over a given week.
Evaluating both aspects of symptomatology allows the clinician to see progress in the
symptoms’ levels of distress and their frequency. This comprehensive approach can be
helpful when assessing progress because patients may still be experiencing symptoms
that are fairly frequent but not as distressing as they previously were. For example,
patients may still be worrying throughout the day but may be better able to shift their
attention, as indicated by progress in therapy. The opposite could be true of other patients
whose frequency of worrying throughout the day is decreasing, but the content of each
worry is still distressing. Gathering specific data on symptomatology can inform
treatment and help the clinician to tailor each session to be the most beneficial for the
patient.
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Additionally, many self-report questionnaires to date do not measure functioning
and positive mental health (Keyes, 2005; Keyes, 2007; Lukat et al., 2016; Suldo &
Shaffer, 2008), two vital components in informing treatment and generating goals.
Overall functioning is crucial in understanding the level of impairment patients’
symptoms are causing. Additionally, positive mental health and psychopathology have
been misunderstood as interrelated (Greenspoon & Saklofske, 2001; Keyes, 2005, Lukat
et al., 2016; Rashid, 2009; Suldo & Shaffer, 2008; Teismann et al., 2018; Trompetter et
al., 2017), such that as psychopathology is reduced, positive mental health automatically
increases. However, research points to these two concepts as being related but ultimately
independent (Greenspoon & Saklofske, 2001; Keyes, 2005; Lukat et al., 2016; Rashid,
2009; Suldo & Shaffer, 2008; Teismann et al., 2018; Trompetter et al., 2017).
The dual-factor model emphasizes that positive mental health is separate from
psychopathology (Greenspoon & Saklofske, 2001; Keyes, 2005; Lukat et al., 2016;
Rashid, 2009; Suldo & Shaffer, 2008; Teismann et al., 2018; Trompetter et al., 2017),
such that clinicians should also be fostering positive mental health in their patients to help
them reach their full potential. Bringing patients to baseline functioning is not enough;
rather, focusing on goals toward increasing positive mental health should also be
included in the treatment plan to help patients self-actualize and grow beyond negative
symptoms (Fava & Ruini, 2003; Trompetter et al., 2017). A standardized and quantitative
measurement of a patient’s level of positive mental health is necessary to assess baseline
functioning and progress throughout treatment (Keyes 2005; Keyes, 2007; Lukat et al.,
2016; Suldo & Shaffer, 2008).
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Positive mental health is highly correlated with problem-solving abilities, such
that an individual who possesses a high level of positive mental health is better able to
approach challenges in life and consider various solutions as opposed to those with low
levels of positive mental health (Frederickson, 2013; Teismann et al., 2018; Tugade &
Frederickson, 2004). Individuals with a healthy well-being are more resilient in the face
of adversity, better regulate their emotions, and are more autonomous than those with low
levels of positive mental health (Frederickson, 2013; Tugade & Frederickson, 2004;
Teismann et al., 2018). Perhaps increasing patients’ positive mental health repertoires can
enhance their confidence and abilities in using the skills and techniques they learned in
therapy to overcome adversity in the future.
The Clinical Outcomes in Routine Evaluation - Outcome Measure (CORE-OM;
Evans et al., 2002) assesses problems/symptoms (12 items), functioning (12 items),
subjective well-being (four items), and risk (six items). It demonstrates high internal
consistency (0.75 - 0.95) and high test-retest reliability (0.87-0.91) for each dimension.
However, the CORE-OM does not follow a coherent structure of items, nor does it
include agenda setting, intensity ratings, or meaningful norms to interpret scores. Owing
to the CORE-OM not following a coherent structure of items, it takes more time to
complete and score. Owing to the inefficiency in scoring, this measure may also produce
more errors. To mediate this concern, the CORE-OM provides software for entering
items to track progress. Although this tool may be viable for clinicians, it poses additional
expenses to clinicians and requires further indirect patient hours. Additionally, the
CORE-OM appears to adequately measure positive mental health and functioning, but
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may lack in the cognitive aspect of symptomatology, as the items tend to focus on
physiological symptoms.
Domains of the Weekly Emotional and Functional Summary
The WEFS is composed of three distinct domains, or subscales: frequency,
intensity, and functioning. The domains are deemed distinct based upon the content
within, as well as in some rating-scale differences. Each domain has factors within that
together create a holistic, comprehensive, and concise way of gathering patient data.
Frequency
The first domain measures how often a given symptom occurs. The frequency
domain includes the following factors: anxiety, depression, anger, positive mental health,
and risk. Assessing the frequency of symptoms helps the clinician to monitor progress.
Understanding how often a given symptom has occurred over the previous week, in
relation to significant life events that may have occurred or any medication changes,
allows the clinician to assess the effect of various factors in the patient’s life. Gathering
these data at the beginning of each session can enhance efficiency by prioritizing
problematic symptoms and contributing to agenda items in the session.
Intensity
The second domain measures the severity of a given symptom for the individual.
The intensity domain includes the following factors: anxiety, depression, anger, positive
mental health, and risk. Most self-report questionnaires to date provide information
relating either to frequency or to intensity. Not many self-report questionnaires to date
record both. Gathering both the frequency of symptoms and the intensity gives the
clinician more information on the patient’s progress. For example, the patient may still be
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experiencing the same amount of worrying and physiological symptoms of anxiety;
however, the intensity may be going down while practicing certain therapeutic skills
learned in session. Gathering only one aspect of symptomatology may lead to misleading
information. Evaluating the intensity and severity of symptoms allows the clinician to
document progress and tailor treatment.
Functioning
Finally, functioning is a single domain and factor that measures the degree to
which an individual can perform well in terms of responsibilities and maintain
relationships while experiencing mental health symptoms. Low scores in the functioning
domain can also measure functional impairments, a criterion in the APA’s (2013)
Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5) for assessing
clinical severity of symptoms. This domain and factor are described in detail later.
Factors of the Weekly Emotional and Functional Summary
The WEFS is unique from other self-report questionnaires in that it encompasses
multiple facets of mental health, including positive mental health and overall functioning
in various areas of life. Clinicians using this measure can gather a comprehensive
understanding of patients’ progress in multiple areas from week to week. The factors
intentionally included in the WEFS are anxiety, depression, anger, risk, positive mental
health, and functioning.
Anxiety
Anxiety disorders are characterized by excessive fear and related behavioral
disturbances (APA, 2013). Fear, in comparison to anxiety, is an adaptive response to a
real or perceived threat, whereas anxiety is the response to anticipatory real or perceived
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threats. Anxiety disorders may differ depending on the stimuli or situation individuals
fear and their behavior or response (APA, 2013). Anxiety disorders include a cognitive
component, such as worrying; a behavioral component, such as avoidance or escaping
feared situations; and a physiological component, such as restlessness (Leahy et al.,
2012).
Anxiety was a crucial factor to include and measure in the WEFS because it is
seen frequently in clinical practice, and its inclusion helps the clinician to better
differentiate between stress and anxiety. As previously stated, an estimated one in four
individuals experience clinical levels of anxiety (Antony et al., 2001; Kessler et al.,
1994). Even with the high rates of anxiety disorders, such diagnoses can often go
undiagnosed as a result of normalizing worrying (Leahy et al., 2012); therefore,
symptoms can go untreated (Antony et al., 2001; Weiller et al., 1998). Therefore, initial
assessment and continual measurement of levels of anxiety in patients are important
because of how common anxiety is, how misunderstood it can be, and its high levels of
comorbidity among other psychiatric disorders (Leahy et al., 2012).
The current study operationally defines and measures anxiety by higher scores on
the following WEFS items: worried, afraid/scared, restless, overwhelmed, and ashamed.
To validate the questions on the WEFS measuring anxiety, two self-report measures are
used for comparison to ensure that the cognitive, behavioral, and physiological
components of anxiety are evaluated. The Beck Anxiety Inventory (BAI; Beck et al.,
1988; Beck & Steer, 1990) is widely used in clinical practice and research settings to
assess level of anxiety specifically related to physiological symptoms, such as sweating
or an increased heart rate when worried, as well as cognitive symptoms (Beck et al.,
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1988; Beck & Steer, 1990). This measure was specifically chosen for the study because
of the profound psychometric properties of the measure and its frequent use.
To assess the validity of the anxiety symptoms items of the WEFS, the PatientReported Outcomes Measurement Information System’s (PROMIS) Emotional Distress
Anxiety, Short Form (PROMIS Health Organization, 2008-2012; Pilkonis et al., 2011)
was used as a comparison. The National Institutes of Health (NIH), a United States
academic institution, funded this group of researchers under the NIH Roadmap for
Medical Research Initiative to develop more accurate patient-reported outcomes for a
variety of settings, including research, mental health, and healthcare. PROMIS created a
self-report measure to assess symptoms, functioning, and health-related quality of life.
Through waves of testing, PROMIS was able to narrow down the number of items on
each self-report to include only the most vital criteria with research to endorse them.
Under the mental health category, self-report measures for emotional distress, cognitive
functioning, and positive psychological functioning were created. Under the emotional
distress category, anxiety, depression, negative psychosocial illness impact, substance,
and anger were developed. PROMIS worked with the APA to include these measures in
the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV; APA, 1994)
and DSM-5 (2013). The PROMIS self-report measures, specifically the emotional distress
category, exhibit promising psychometrics, making it a viable option for the purpose of
this study.
Depression
Depressive disorders share common characteristics of sadness, empty feelings,
irritability, and negative thought patterns (APA, 2013). Criteria for depressive disorders
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account for and differentiate general levels of sadness, grief, and bereavement (APA,
2013). Patients are diagnosed with depressive disorders when their negative thought
patterns, physiological symptoms, behaviors, and emotions are outside the normal
response to a stressor. According to the cognitive model, depression is characterized as
negative thoughts about the self, others, and the future (Leahy et al., 2012), as well as a
lack of reward from the environment (Leahy et al. 2012). These pervasive thoughts are
believed to negatively impact physiological symptoms (e.g., fatigue), behaviors (e.g.,
isolation), and emotions (i.e., sadness and emptiness).
When developing the WEFS, depression was a crucial factor to include and
measure because of its prevalence in clinical practice and its ability to better differentiate
between sadness and depression. As previously stated, depression has been called the
“common cold” of psychological disorders because of its prevalence and significance
(Nezu et al., 2000). With approximately 300 million people diagnosed with depression at
some point in their lifetimes globally (World Health Organization, 2017) and its high
comorbidity rates (Leahy et al., 2012), depression is important to assess and monitor
throughout treatment.
The current study operationally defines and measures depression by higher scores
on the following WEFS items: sad, guilty, lonely, apathetic, and hopeless/helpless. To
assess the validity of the depression items of the WEFS to ensure that cognitive,
behavioral, and physiological symptoms are accurately measured, the Quick Inventory of
Depressive Symptomatology, Self Report (QIDS-SR; Rush et al., 2003) and the PROMIS
Severity Measure for Depression, Adult (PROMIS Health Organization, 2008-2012;
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Pilkonis et al., 2011) were used. Both of these measures have high validity and reliability
rates when used in clinical practice.
The QIDS-SR (Rush et al., 2003) was adapted from the 30-item self-report, the
Inventory of Depressive Symptomatology ( Rush et al., 2000). In a study by Brown et al.
(2008), the QIDS-SR was compared to the IDS-SR and the Hamilton Rating Scale for
Depression (HRSD) to assess for validity of the short form. The researchers of this study
found a high correlation between the IDS-SR (r = 0.97) and the HRSD (r = 0.85),
suggesting that the short form is highly correlated with the original form, and with a
widely used standardized measure. The short form of this self-report measure was
intentionally chosen as to avoid exhausting participants by asking them to complete
multiple lengthy questionnaires as a part of the current study.
The PROMIS Severity Measure for Depression, Adult (Pilkonis et al., 2014) is
identical to the Patient Health Questionnaire (PHQ-9; Spitzer et al., 1999), which exhibits
excellent psychometric properties, but has been adjusted to fit a recall period of 1 week,
rather than 2. This decision was intentional, as having the same recall period was
imperative for standardization.
Anger
According to Cella et al. (2010), anger can be defined as an angry mood, such as
irritability and reactivity to others; negative thoughts about others, such as envy or
vengefulness; verbal aggression; and difficulties controlling one’s anger. Anger does not
include physical aggression toward others (Cella et al., 2010). When developing the
WEFS, anger was included as a factor because it is a common underlying symptom of
various mental disorders. In fact, anger has been recognized as a common symptom
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indicative of emotional distress (Cella et al., 2010). Negative emotions, such as anger and
hostility, have been correlated with an increased physiological arousal and a higher risk
of stress-related diseases (Suls & Bunde, 2005). Studies have shown that unexpressed
anger can lead to depressive features, guilty feelings, anxiety, passive aggressiveness, and
resentment of others (Kopper & Epperson, 1996). Therefore, assessing and treating
anger, along with other emotional distress symptoms, is important to prevent and reduce
rates of stress-related disorders. The PROMIS researchers believed that anger is present
as a symptom in many different DSM-5 (2013) diagnoses and, therefore, accounting for it
in patients is important (Schalet et al., 2016).
The current study operationally defines and measures anger by higher scores on
the following WEFS items: annoyed, bitter, frustrated, angry, and hostile. To assess the
validity of the anger items of the WEFS, the PROMIS Emotional Distress Anger, Short
Form (PROMIS Health Organization, 2012) was used as a standardized comparison. As
previously stated, PROMIS researchers developed measures through comprehensive
literature reviews, organization of items, qualitative item reviews, focus groups with
patients, standardization of items, and factor analyses. The short forms were highly
correlated with the long forms and acceptable for use in clinical and research practice.
The psychometric properties of the PROMIS Emotional Distress Anger, Short Form,
measure have been confirmed through a varied sample (PROMIS Health Organization,
2012).
Risk
For the current study, risk is defined as suicidal and homicidal ideation. Patients
who endorse having thoughts about inflicting harm upon themselves or others are
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characterized as high “risk.” Suicidality is characterized as one’s desire and intent to
inflict harm on onself or kill oneself. Homicidality is operationally defined as one’s
desire and intent to inflict harm on or kill others. Keeping patients and the public safe is
an ethical and legal duty of mental health professionals (APA Ethics Code Standard
4.05b, Disclosures). Owing to this law and ethical guideline, suicidality and homicidality
should be routinely assessed.
To assess the validity of the suicidality and homicidality items on the WEFS, the
CORE-OM (Evans et al., 2002) was used. The CORE-OM was chosen because it
displays excellent psychometric properties and measures four dimensions: subjective
well-being, problems/symptoms, life functioning, and risk and harm. Included in the risk
dimension are questions regarding suicidality and homicidality, such as, “I have thoughts
of hurting myself” and “I have threatened or intimidated another person.”
Positive Mental Health
Positive mental health has been defined as the presence of emotional,
psychological, and social well-being, such that one is flourishing in these areas (Keyes,
2005; Keyes 2007; Lukat et al., 2016) while having high levels of positive affect and
satisfaction and low levels of negative affect (Deci & Ryan, 2008). Having a purpose in
life, being connected socially to others, experiencing positive emotions, and accepting
oneself are also traits of individuals with positive mental health (Trompetter et al., 2017).
Positive mental health is crucial to measure and foster in patients because it brings them
from baseline and beyond to their optimal level of functioning. Positive mental health has
been shown to be correlated with facing adversity, problem solving, regulating emotions,
and autonomy (Frederickson, 2013; Teismann et al., 2018; Tugade & Frederickson,
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2004). Positive mental health is subjective in nature and therefore needs a self-report to
adequately measure (Deci & Ryan, 2008).
The current study operationally defines and measures positive mental health by
higher scores on the following WEFS items: content, self-confident, optimistic,
worthwhile, connected to others, adequate/good enough, in control of my emotions,
interesting, attractive, and grateful. The CORE-OM was used as a standardized measure
to compare to the positive mental health factor on the WEFS. The CORE-OM includes a
dimension of subjective well-being with items related to optimism for the future and
individuals’ feelings about themselves.
Functioning
Functioning can be characterized by one’s level of inability or ability to carry out
responsibilities at home and at work, as well as in relationships at home, at work, with
friends, and with family. Functioning is important to assess because it can provide data
regarding levels of impairment. Are patients able to go to work but are not as productive
as they could be because of their symptoms? Or, are patients not even able to leave their
home anymore? Understanding level of impairment can help the clinician evaluate the
patient’s quality of life and the level of dysfunction caused by the patient’s symptoms,
furthering the clinician’s understanding of each patient.
The current study operationally defines and measures one’s level of functioning
by higher scores on the following WEFS items: relationships at home, responsibilities at
home, relationships with friends, relationships with coworkers/classmates, performance
at work/school, use of leisure time, and physical health. To assess the validity of the
functioning items of the WEFS, the CORE-OM was used because it includes a dimension
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of functioning, with items related to coping (e.g., “I have felt able to cope when things go
wrong”) and interpersonal relationships (e.g., “I have felt terribly alone and isolated”).
The functioning dimension of the CORE-OM includes 12 items measuring functioning,
making it a viable comparison for the WEFS.
Additional Factors of the Weekly Emotional and Functional Summary
Aside from gathering data on mental health symptoms, the WEFS also assesses
information regarding significant life events that occurred during the previous week,
medication changes, and the patient’s input on agenda items. The WEFS is believed to
contribute to a holistic approach, while also increasing efficiency.
Significant Changes
The WEFS self-report questionnaire includes a few questions outside of
symptomatology for patients to record. One of these questions asks about significant
changes or life events that may have occurred over the previous week that the patient
would like to discuss in session. This efficient way of gathering information from the
patient can influence the productivity of the therapy session. Assessing significant life
events also allows patients time to evaluate the previous week and reflect upon the
possible influence of an event on their symptoms. This question can improve efficiency,
as it encourages patients to think about the previous week in the waiting room prior to
their appointment.
Psychiatric Medication Changes
Gathering psychiatric medication changes helps the clinician to document
changes, remember to address medication changes with patients, and see if these
adjustments impacted the patients’ scores on each facet of their mental health. Assessing
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psychiatric medication changes allows the clinician to gather a more holistic
understanding of a patient’s progress. These miscellaneous items included in the WEFS
promote a comprehensive case conceptualization to aid clinicians in tailoring treatment.
Agenda Setting
The WEFS self-report questionnaire is also unique in that it fosters collaboration
by asking patients what they would like to add to the session’s agenda. This item, which
is oriented to cognitive-behavioral therapy-, provides an efficient way of gathering
information from the patient that allows the clinician to collaborate on agenda items for
the therapy session. After completing the self-report questionnaire and thinking through
the previously stated questions, patients are asked what they would like to address in
session. Agenda setting helps patients to feel that their opinions are valued. Collaborating
on desired accomplishments in each session empowers patients to help take control of
their treatment and reach their goals (Hatcher, 1999; Wolfe & Pincus, 1999).
The WEFS helps to inform and tailor treatment for each specific session.
Understanding patients’ levels of anxiety, depression, anger, and risk, along with their
positive mental health and overall functioning, allows clinicians to adapt treatment and
meet patient needs from week to week. Without doing so, clinicians may risk missing
increased depressive symptoms while treating an anxiety disorder, for example.
Gathering session-by-session data not only enhances progress toward treatment goals, but
also ensures that valuable information is not missed and is included in treatment.
Feedback
At the end of each session, the WEFS includes an adapted version of the Session
Rating Scale ( Duncan et al., 2003) feedback measure. This feedback measure asks
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patients to reflect on their session and evaluate their perceived relationship with their
clinician, on whether the topics discussed helped them reach the goals they had set for
themselves, on whether they appreciated the clinician’s approach, on whether they
learned ways to cope with their psychological problems, and on the overall session.
Asking for feedback can help patients feel valued and heard and can provide the clinician
with information regarding better ways to serve their patients.
A study conducted by Lambert et al. (2001) evaluated the effects of patients
providing therapists with feedback. They split patients into an experimental group and a
control group. Clinicians were instructed to ask the experimental group for feedback
regarding their session. Clinicians were instructed not to ask patients in the control group
for feedback. When comparing the two groups on retention rates, patients in the
experimental group attended more therapy sessions and had improved outcomes in
comparison to the control group. Furthermore, twice as many patients in the experimental
group reached clinically significant changes in their symptoms (Lambert et al., 2001).
These results provide evidence for the impact that feedback can have not only on
retention rates, but also on clinically significant changes. Some patients may be timid or
not know how to share their feedback unless formally assessed.
Psychometric Characteristics of Self-Report Measures
In order for a psychological test to be deemed useful in clinical practice, it must
exhibit certain characteristics. According to Kline (2015), a useful psychological test
must have at least an interval scale to represent meaningful differences between scale
points so that scores can be compared and analyzed, but preferably a ratio scale with a
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meaningful zero scale point. Additionally, it must be reliable, valid, discriminating, and
show precise norms (Kline, 2015).
When developing self-report measures, evidence of reliability and validity is a
fundamental requirement (Kazdin, 2003; Kline, 2015). More specifically, evidence of
consistency within the measure and data supporting that the questionnaire measures the
constructs it intends to measure are essential (Kazdin, 2003; Kline, 2015). In regard to
reliability, a useful psychological test must be internally consistent, produce similar
scores across populations, and be stable over time. Test construction emphasizes internal
consistency as necessary before assessing for validity (Kline, 2015). That is, in order to
determine if the test measures what it intends to measure, the items first have to be
deemed related. Additionally, stability over time (i.e., test-retest reliability) is a valuable
psychometric characteristic in self-report outcome measures because exhibiting
measurement sensitivity would support score fluctuations as treatment progresses
(Kazdin, 2003).
At the center, if a test measures what it intends to measure, it has achieved
validity. To achieve validity, one or more types of validity must be exhibited within the
measure (Kazdin, 2003). Whether a self-report questionnaire measures a construct of
interest is commonly evaluated through the use of multiple questionnaires, as is the case
with convergent validity (Kazdin, 2003). Face validity assesses the degree to which the
purpose of the self-report measure is apparent to the individuals completing the scale.
Concurrent validity targets how highly correlated a measure is with other standardized
measures in the respective areas. Predictive validity evaluates if a measure is able to
predict outcomes on a related variable. Additionally, content validity targets whether the
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scale assesses all aspect of a variable, and construct validity measures how well the scale
assesses a given construct. When assessing for the content of a measure, securing items
that are distinct to a given construct and separating them from others that are not related
also is valuable (Kline, 2015).
Additional psychometric characteristics that assess the usefulness of a
psychological test include discriminatory power and standardization and norms.
Discriminatory power is the degree to which a measure exhibits a spread of scores,
leading to the establishment of norms and increasing the meaningfulness of a given score
(Kline, 2015). Developing standardized scores over time to create norms significantly
increases the utility of a psychological test.
The following study on the WEFS, a psychological test, is preliminary. Therefore,
certain psychometric characteristics were chosen in exploring the utility of the measure
for clinical practice. First, exploring the factor structure was deemed a prerequisite in
examining the validity of the measure. To follow, construct validity, convergent validity
measurements, internal consistency, and test-retest reliability were emphasized.
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CHAPTER 3: METHOD
Design
The present study was correlational. This quantitative study used archival data
from a mental health center in northeastern Pennsylvania to assess the psychometric
properties of the Weekly Emotional and Functional Summary (WEFS; Salas, 2018). The
Beck Anxiety Inventory (BAI); PROMIS Emotional Distress Anxiety, Short Form; Quick
Inventory of Depressive Symptomatology, Self-Report (QIDS-SR); PROMIS Severity
Measure of Depression, Adult; PROMIS Emotional Distress Anger, Short Form; Clinical
Outcomes in Routine Evaluation – Outcome Measure (CORE-OM), and the Positive
Affect and Negative Affect Schedule (PANAS) were used as standardized measures to
compare to the following WEFS factors: anxiety, depression, anger, risk, positive mental
health, and functioning.
Participants
The present study used a deidentified convenience sample of 153 adult patients
seeking mental health treatment at an outpatient mental health center in northeastern
Pennsylvania. Willing participants were assessed at time of intake and 1 week following
the intake appointment prior to treatment.
Inclusion and Exclusion Criteria
The study inclusion criteria included (a) being a patient of the center at the time of
intake and 1 week following, (b) having the ability to read and understand English at an
8th grade level, and (c) being at least 18 years old.
Potential participants were excluded if they (a) were not a patient at the center, (b)
had an English reading level below 8th grade, and (c) were younger than 18 years old.
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Measures
When selecting standardized measures to compare to the WEFS, self-report
questionnaires were chosen based upon psychometric properties, brevity, and quality. To
ensure standardization and consistency, all of the measures chosen included instructions
for patients to recall symptoms over the previous 7 days.
Weekly Emotional and Functional Summary
The WEFS consists of 34 items intended to measure anxiety, depression, anger,
harm, positive mental health, and functioning in psychiatric populations. The WEFS is a
new, untested measure for which there are currently no psychometric properties. The
purpose of the present study was to evaluate the psychometric properties of the WEFS by
assessing for construct validity through a factor analysis, convergent validity, and testretest reliability.
Beck Anxiety Inventory
The BAI (Beck et al., 1988) consists of 21 items to measure the severity of
anxiety in psychiatric populations. Items on the BAI reflect neurophysiological,
subjective, panic, and autonomic symptoms of anxiety. Patients are instructed to report
their severity of anxiety symptoms on a 4-point Likert scale Not at all to Severely, I could
barely stand it) over the previous 7 days. Scores on the BAI range from 0 to 63, with
scores from 0 to 7 reflecting a minimal level of anxiety, 8 to 15 reflecting a mild level of
anxiety, 16 to 25 reflecting a moderate level of anxiety, and 26 to 63 reflecting a severe
level of anxiety. The BAI has shown high internal consistency (α = 0.92), test-retest
reliability after 1 week (r = 0.75), and after 5 weeks (r = 0.83). The BAI also
demonstrated convergent and discriminant validity among panic disorder, generalized
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anxiety, major depressive disorder, and dysthymic disorder. The BAI demonstrates a high
correlation with the Hamilton Rating Scale for Anxiety (HRSA; r = 0.51) and a weaker
correlation with the Hamilton Depression Rating Scale for Depression (HRSD; r = 0.25).
PROMIS Emotional Distress Anxiety, Short Form
The PROMIS Emotional Distress Anxiety, Short Form (PROMIS Health
Organization, 2012) consists of seven questions measuring predominantly cognitive
symptoms of anxiety. The items on this measure focus on fear, anxious misery,
hyperarousal, and somatic symptoms of arousal. Patients are asked to report the severity
of anxious symptoms on a 5-point Likert scale (1 = Never to 5 = Always) over the
previous 7 days. Scores range from 7 to 35, with higher scores indicating more severe
anxiety. This measure has been adapted from the original PROMIS Emotional Distress
Anxiety inventory that consisted of 29 items. The original inventory was extensively
researched by the patient-reported outcomes measurement and information system
(PROMIS), a company founded by the National Institutes of Health. In developing selfreport measures to be included in the DSM-5 (2013), researchers used literature reviews,
focus groups, item reviews, cognitive interviewing, and item and scale calibrations based
on item response theory models. The original inventory demonstrated convergent validity
when compared to the Generalized Anxiety Disorder-7 (r = 0.92), the Kessler 6
Psychological Distress Scale (r = 0.88), and the Mood and Anxiety Symptoms
Questionnaire (r = 0.80). The seven-item short form is highly correlated with the original
inventory (α = 0.96) and demonstrates excellent reliability (r = 0.89). The researchers
noted that the full item banks provide the most information regarding symptoms, but the
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short forms still exhibited high psychometric properties when compared to legacy
measures.
Quick Inventory of Depressive Symptomatology – Self Report
The QIDS-SR (Rush et al., 2003) consists of 16 items measuring the severity of
depressive symptoms, including quality of sleep, sad mood, appetite, concentration,
views of self, suicidal ideation, interests in activities, and energy level. Patients are
instructed to rate their level of impairment in each domain of depressive symptomatology
on a 4-point Likert scale over the previous 7 days. Scores range from 0 to 27, with scores
from 6 to 10 reflecting mild depression, 11 to 15 reflecting moderate depression, 16 to 20
reflecting severe depression, and 21 to 27 reflecting very severe depression. The QIDSSR has been adapted from the Inventory of Depressive Symptomatology Self-Report
(IDS-SR). The QIDS-SR demonstrated high internal consistency and concurrent validity
with the IDS-SR30 (α = 0.86) and with the HRSD (α = 0.87).
PROMIS Severity Measure of Depression, Adult
The PROMIS Severity Measure of Depression, Adult (PROMIS Health
Organization, 2012) has been adapted from the Patient Health Questionnaire-9 (PHQ-9;
Spitzer et al., 1999) for research and evaluation purposes to adjust the time frame of
measurement from 2 weeks to 1 week. The PHQ-9 consists of nine questions measuring
various domains of depressive symptomatology, such as interest in activities, feelings of
sadness, quality of sleep, energy, appetite, self-esteem, concentration, and suicidality.
Patients are instructed to report severity of symptoms on a 4-point Likert scale (0 = Not
at all to 3 = Nearly every day) over the previous 7 days. Scores range from 0 to 27, with
scores ranging from 5 to 9 reflecting mild depression, scores ranging from 10 to 14
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reflecting moderate depression, scores ranging from 15 to 19 reflecting moderately severe
depression, and scores ranging from 20 to 27 reflecting severe depression. The PHQ-9 is
a self-report measure that was adapted from the full PHQ, which was adapted from the
Primary Care Evaluation of Mental Disorders, a screening instrument designed for use in
primary care. The PHQ-9 is highly correlated with other measures of depression, such as
the Beck Depression Inventory (BDI; r= 0.73) and the General Health Questionnaire (r =
0.59; Kroenke, K., Spitzer, R. L., & Williams, J. B., 2001; Kroenke, K., & Spitzer, R. L.,
2002; Martin, 2006).
PROMIS Emotional Distress Anger, Short Form
The PROMIS Emotional Distress Anger, Short Form (PROMIS Health
Organization, 2012) consists of five items to assess angry mood and efforts to control
anger. Anger is commonly conceptualized as attitudes of hostility and cynicism, marked
by verbal and nonverbal behaviors that impede goal-directed behavior. Physical
aggression is not included in this measure. Patients are instructed to rate their level of
anger on a 5-point Likert scale (1 = Never to 5 = Always) over the previous 7 days.
Scores range from 5 to 25, with higher scores reflecting more severe levels of anger.
Scores are computed into t scores, with less than 55 reflecting none to slight levels of
anger, 55.0 to 59.9 reflecting mild levels of anger, 60.0 to 69.9 reflecting moderate levels
of anger, and 70 and greater reflecting severe levels of anger. The PROMIS Emotional
Distress Anger, Short Form, exhibits strong reliability with the PROMIS Emotional
Distress Anger, Full Scale (α = 0.96), which is highly correlated with the Aggression
Questionnaire (r = 0.51).
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Clinical Outcomes in Routine Evaluation – Outcome Measure
The CORE-OM (Evans et al., 2002) consists of 34 questions measuring subjective
well-being, symptoms, functioning, and risk. Four items measure subjective well-being.
Twelve items measure symptoms, including anxiety, depression, physical, and trauma.
Twelve symptoms measure functioning, including overall functioning, close
relationships, and social relationships. The remaining six items, including harm to self
and to others, measure risk. The CORE-OM was created to provide clinicians with a
baseline and ongoing assessment of psychological distress, including important aspects of
psychological well-being that clinicians find most useful.
The scale uses a 5-point Likert scale (0 = Not at all to 4 = Most or all of the time).
Total scores range from 0 to 136, with higher scores indicating lower levels of well-being
and functioning, severe symptoms, and suicidal or homicidal ideation. More specifically,
on the well-being dimension, scores range from 0 to 16, with higher scores indicating
deficits in well-being. Scores on the symptoms dimension range from 0 to 48, with higher
scores indicating more severe levels of psychiatric symptoms. Scores on the functioning
dimension range from 0 to 48, with higher scores indicating deficits in functioning.
Scores on the risk dimension range from 0 to 24, with higher scores indicating patients at
risk for suicidal or homicidal ideation. The CORE-OM displayed high internal
consistency ranging from 0.75 to 0.95 for each dimension (Evans et al., 2002). Test-retest
reliability was high as well, with scores ranging from 0.87 to 0.91 for each dimension.
The CORE-OM’s symptoms subtype of anxiety scale was positively correlated to the
BAI (0.74), and the depression subtype was closely related to the BDI-II (0.68). The
CORE-OM’s symptoms dimension was also positively correlated with the Brief
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Symptoms Inventory (0.76), the Symptom Checklist (0.87), and the General Health
Questionnaire-Somatic Symptoms (GHQ-A; 0.60), and the GHQ-Anxiety (0.61). The
well-being dimension was correlated with the BDI-II (0.79) and the GHQ (0.67) and the
General Health Questionnaire-Social Dysfunction (GHQ-C; 0.60). The functioning
dimension was correlated with the BDI-I (0.78) and the GHQ-C (0.60), and the General
Health Questionnaire-Depression (GHQ-D; 0.55). The risk dimension was correlated
with the GHQ-D. These correlations represent excellent convergent validity for the
CORE-OM (Evans et al., 2002).
Positive and Negative Affect Schedule
The PANAS (Watson et al., 1988), consists of two 10-item scales measuring
positive affect and negative affect. Each item consists of one adjective that is rated on a
5-point Likert scale (1 = Very slightly to not at all to 5 = Extremely). Patients are
instructed to report how well an adjective describes them over the previous week. High
negative-affect scores reflect a higher level of subjective distress. Low negative-affect
scores reflect an absence of subjective distress. High positive-affect scores reflect
enthusiasm and alertness. Low positive-affect scores reflect lethargy and sadness. Low
positive-affect scores are more closely related to depression diagnoses, and high
negative-affect scores are more closely related to anxiety diagnoses. Test-retest reliability
demonstrated a range from 0.39 to 0.71 with an 8-week interval time. When compared to
the Hopkins Symptom Checklist, the BDI, and the State-Trait Anxiety Inventory, the
positive-affect scale correlations ranged from -0.19 to -0.36, and the negative-affect scale
correlations ranged from 0.51 to 0.74.
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Procedures
The study was conducted using archival data from 153 patients at a mental health
center in northeastern Pennsylvania. Staff members at the private practice collected the
archival data. Each patient interested in an intake appointment completed various forms
for the center, including eight self-report questionnaires and brief demographic
information (i.e., gender, age, ethnicity). The patients had the choice of completing the
self-report measures by printing them from the center’s website, by having the self-report
measures emailed to them, by having the self-report measures mailed to their home
address, or by completing the self-report measures at the center prior to their scheduled
appointment. If patients were not able to complete the self-report measures before their
first appointment, they were asked to complete them before coming to their second
appointment, prior to treatment. Completing self-report measures before the second
appointment happened on only two occasions.
After completing the required forms for an intake appointment (including the selfreport measures), patients were given the option to consent and allow staff members to
deidentify their scores on the eight self-report measures (and the WEFS again 1 week
after the intake) to be used for research purposes. Consent forms were filed in a locked
drawer at the private practice’s office. Patients were instructed to provide the completed
self-report measures to their clinician, who checked for completion. Clinicians were
instructed to return the self-report measures from patients whot consented to research to
the staff members after the intake appointment to deidentify and code the data. Clinicians
were instructed to keep the self-report measure for treatment purposes if patients did not
consent to research.
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Staff members at the private practice then scored the self-report measures of those
who consented to the study and met the inclusion criteria and created a data set. The data
set included general demographic information (i.e., gender, age, and ethnicity), primary
psychiatric diagnoses (and when necessary, secondary psychiatric diagnoses),
deidentified scores on the self-report measures, and deidentified scores on each item of
the WEFS at the time of intake and 1 week following.
The deidentification process included the removal of direct patient identifiers,
such as names, addresses, email addresses, and telephone numbers. The patient identifiers
were replaced with randomly generated numbers and added to the data set. Raw data
were returned to the patients’ clinicians with an interpretation of their scores for
treatment purposes. Raw data were also kept locked in patients’ charts in the private
practice’s office. After approval was received from the Institutional Review Board, the
deidentified archival data set was given to the principal investigator and converted to an
SPSS file for further analysis.
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CHAPTER 4: RESULTS
Introduction
The researchers employed principal component factor analyses to validate the
proposed factor structure and correlational analyses to evaluate the psychometric
properties of the Weekly Emotional and Functional Summary (WEFS). More
specifically, correlations were conducted to assess the consistency of the WEFS scale
scores over time and to examine the relationship between the factors of the WEFS and
other standardized measures. In addition, a coefficient alpha was calculated to assess the
internal consistency of the items within each factor to further assess the psychometric
properties of the self-report measure.
Demographic Analyses
To investigate the psychometric properties of the WEFS in a clinical sample, an
archival data set consisting of 153 participants seeking mental health treatment at an
outpatient mental health practice in northeastern Pennsylvania was analyzed. Of the 207
participants, 54 individuals did not complete the surveys or omitted items, thus leaving
153 individuals who completed the WEFS. The data from these 153 participants were
used for the investigation of the WEFS factor structure and internal consistency reliability
analysis. Additionally, 27 individuals did not complete the ethnicity section of the
demographic questionnaire, leaving 128 individuals with completed demographic
information.
The demographic characteristics, including age, gender, ethnicity, primary
diagnosis, and, when necessary, secondary diagnosis, were assessed and analyzed for
trends. Of the 207 participants who completed all survey and demographic
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questionnaires, 94 were female (61%) and 59 were male (39%). In regard to age, 59 fell
into the 18- to 29-yearage range (38.7%), 34 fell in the 30- to 40-year age range (22%),
and 60 fell in the age 41- to 85-year age range (39.3%). The mean age of the sample was
38 years old (SD = 15).
Table 1 lists frequency distributions for the ethnicities endorsed by participants in
the study. One should note that 27 participants (17.4%) did not endorse an ethnicity. As
evident by the demographic statistics, the sample was not as diverse as researchers had
hoped. The sample consisted predominantly of European Americans (55.5%), with little
diversity in ethnicity.
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Table 1
Demographic Analyses for Ethnicity
Ethnicity

Frequency

Percent

Native American

2

1.3

Asian

6

3.9

African American

9

5.8

Hispanic

11

7.2

European / Caucasian

85

55.5

Arab

4

2.6

Jewish

1

0.6

Hindu

1

0.6

Other

7

4.5

Missing

27

18

Total

128

82

In regard to psychiatric diagnoses, 153 participants’ primary diagnostic codes
were assessed and analyzed as well. Table 2 details the classifications of primary
psychiatric diagnoses of the sample. One should note that 18 participants (11.6%) did not
receive a psychiatric diagnosis at the time of data collection. Missing data for this
demographic variable may be the result of diagnoses not yet added to patient charts at the
time of data collection or diagnoses deferred. The most common primary psychiatric
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diagnosis was anxiety disorders (32%), followed by trauma- and stressor-related
disorders (28%), and depressive disorders (17%). The sample exhibits expected
diagnoses for a sample seeking outpatient mental health treatment.

Table 2
Demographic Analyses for Primary Psychiatric Diagnosis
Frequency

Percent

Bipolar and Related Disorders

8

5.3

Depressive Disorders

27

17.7

Anxiety Disorders

50

32.7

Obsessive-Compulsive Disorder

1

0.6

Trauma and Stressor-Related Disorders

43

28

3

2

Dissociative Disorders

1

0.6

Neurodevelopmental Disorders

2

1.3

Missing

18

11.8

Total

153

100

Psychiatric diagnosis

Somatic Symptom and Related Disorders

Note. Diagnoses based upon the Diagnostic and Statistical Manual of Mental Disorders (5th ed.).
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Of the 153 participants, 66 participants received a secondary psychiatric
diagnosis. Table 3 details the classifications of secondary psychiatric diagnoses of the
sample. The most common secondary psychiatric diagnosis was anxiety disorders (39%),
followed by depressive disorders (25%) and trauma- and stressor-related disorders (16%).
The sample exhibits expected diagnoses for a sample seeking outpatient mental health
treatment.
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Table 3
Demographic Analyses for Secondary Psychiatric Diagnosis
Psychiatric diagnosis

Frequency

Percent

Depressive Disorders

17

25

Anxiety Disorders

26

39

Obsessive-Compulsive Disorder

3

4

Trauma and Stressor-Related Disorders

11

16

Dissociative Disorders

1

1.5

1

1.5

3

4

2

3

Personality Disorders

1

1.5

Other Conditions

1

1.5

Total

66

100

Neurodevelopmental Disorders
Sleep-Wake Disorders
Substance-Related and Addictive Disorders

Note. Diagnoses based upon the Diagnostic and Statistical Manual of Mental Disorders (5th ed.).

Participation in the study was voluntary, and all participants remained
anonymous. The only identifying information gathered was the previously mentioned
demographic data.
Means and standard deviations for each self-report measure and, when applicable,
subscales within were calculated as well to show how participants in the sample tended to
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score on each measure. Table 4 lists average participant scores for standardized selfreport measures used for construct validity analyses. One should note that eight
participants (5%) did not complete the Positive Affect and Negative Affect Scale
(PANAS).
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Table 4
Participant Self-Report Measure Scores
Mean
score

Standard
deviation

Score
rangea

PROMIS Emotional Distress Anxiety, Short
Form

62.05

9.51

(36.3 –
82.7)

PROMIS Severity Measure of Depression,
Adult

9.86

6.61

(0 – 26)

Quick Inventory of Depressive
Symptomatology – Self Report

12.52

7.36

(0 – 32)

PROMIS Emotional Distress Anger, Short
Form

53.82

10.67

(32.9 –
83.3)

Positive Affect Subscale of the PANAS

25.23

8.58

(10 – 47)

Negative Affect Subscale of the PANAS

25.72

8.57

(10 – 47)

Well-being Subscale of the CORE-OM

8.23

3.89

(0 – 16)

Psychiatric Subscale of the CORE-OM

21.96

10.85

(0 – 46)

Functioning Subscale of the CORE-OM

16.74

8.99

(0 – 36)

Risk Subscale of the CORE-OM

0.99

2.15

(0 – 11)

Beck Anxiety Inventory

14.14

10.5

(0 – 46)

Self-report measure

Note. Patient-Reported Outcomes Measurement Information System (PROMIS), Positive Affect
and Negative Affect Scale (PANAS), Clinical Outcomes in Routine Evaluation - Outcome
Measure (CORE-OM)
a
Score ranges based upon scoring instructions for each measure.
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Hypothesis 1
Three separate principal components factor analyses were conducted for each
domain of the WEFS. The first domain and factor analysis calculated was frequency of
endorsement of symptoms, followed by intensity of endorsement of symptoms and
perception of functioning. The factors in each domain were intercorrelated to assess
relationships within the overall scale.
Factor Analysis of WEFS Frequency Domain
The first analyzed domain of the WEFS was frequency. Individuals who score
high on this domain typically endorse experiencing distressing psychiatric symptoms at a
high frequency or occurrence within a week. The only exception is with the positive
mental health factor, in which high scores indicate a high frequency or occurrence of
protective factors, such as self-confidence and optimism.
In order to test whether the frequency ratings of the WEFS demonstrated
construct validity and to further investigate the factor structure of the measure, a principal
components factor analysis with varimax rotation using the Kaiser criterion was
conducted. The 27 items from the WEFS were analyzed, and the rotated component
matrix revealed six factors. Using a minimum factor loading criterion of .40 for items in
each factor, six factors were retained. This factor loading criterion accounted for 68.60%
of the total variance. Table 5 presents the description and distribution of items’
corresponding factors, along with each item’s factor loading. A Kaiser-Meyer-Olkin
(KMO) statistic was found to be strong (KMO = 0.883), suggesting that the inter-item
correlations are relatively compact, and thus, the factor analysis should yield distinct and
reliable factors. Also, the Bartlett’s test of sphericity was found to be significant (p <
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.0001). This significance suggests that each item correlates significantly with other items
and a factor analysis is appropriate for this dataset.
Items that loaded uniquely to one factor were included; therefore, items that
loaded on two or more factors were omitted unless otherwise noted. Additionally,
individual factors with only one or two items were discarded and not interpretable,
leaving three interpretable factors. Results indicate that items that loaded on individual
factors closely reflect three of the five hypothesized factors: Positive Mental Health,
Anxiety, and Anger.
Factor 1, Positive Mental Health, included eight items. Individuals who score high
on this factor endorse frequently experiencing protective factors. This factor included a
combination of items that described positive mental health, including content, selfconfident, optimism, adequate/good enough, in control of my emotions, interesting,
attractive, and grateful. These items generally reflect the degree to which individuals feel
positively about themselves. The items that did not load on this factor include worthwhile
and connected to others.
Factor 2, Anxiety, included four items. Individuals who score high on this factor
endorse frequently experiencing distressing symptoms related to clinical anxiety. This
factor included a combination of items that described anxiety symptoms, including
worried, afraid/scared, restless, and overwhelmed. These items generally reflect the
degree to which individuals experience anxiety symptoms. The item that did not load on
this factor was ashamed.
Factor 3, Anger, included four items. Individuals who score on this factor endorse
frequently experiencing the emotion, anger. This factor included a combination of items
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that described anger, including annoyed, bitter, frustrated, and angry. These items
generally reflect the degree to which individuals experience the emotion anger. The item
that did not load on this factor was hostile.
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Table 5
WEFS Frequency Factor Loadings
Factor 1:

Positive Mental Health

Item

Loading

Item 16: Content

0.753

Item 17: Self-confident

0.777

Item 18: Optimistic

0.849

Item 21: Adequate/Good enough

0.658

Item 22: In control of my emotions

0.598

Item 23: Interesting

0.716

Item 24: Attractive

0.757

Item 25: Grateful

0.714

Factor 2:

Anxiety

Item

Loading

Item 1: Worried

0.689

Item 2: Afraid/scared

0.740

Item 3: Restless

0.793

Item 4: Overwhelmed

0.715
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Anger

Item

Loading

Item 1: Annoyed

0.816

Item 2: Bitter

0.708

Item 3: Frustrated

0.704

Item 4: Angry

0.840

Note. WEFS = Weekly Emotional and Functional Summary.

Table 6 lists the eigenvalues and the percentage of variance explained by the
factors for the individual WEFS Frequency factors using rotation sums of squared
loadings. The percentages of variance, as well as the cumulative percentage variance, are
presented for each factor.
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Table 6
Eigenvalues and Explanation of Variance by WEFS Frequency Factor
Factor

Eigenvalues

% of variance

Cumulative %

1

5.665

20.983

20.983

2

3.779

13.995

34.978

3

3.448

12.771

47.749

Note. WEFS = Weekly Emotional and Functional Summary.

WEFS Frequency Coefficient Alpha Reliability
To investigate the internal consistency reliability of the WEFS, a total scale
estimate of internal reliability was calculated using Cronbach’s coefficient alpha. Also,
domain estimates of internal consistency were calculated for each factor. Coefficient
alpha data for the total scale and each factor are listed in Table 7.
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Table 7
Coefficient Alpha Reliability for Individual WEFS Frequency Factors
Factor

Description

Coefficient Alpha

1

Positive Mental Health

0.910

2

Anxiety & Depression

0.839

3

Anger

0.855

Total WEFS Frequency Scale Coefficient Alpha = 0.646
Note. WEFS = Weekly Emotional and Functional Summary.

Factor Analysis of WEFS Intensity Domain
The second analyzed domain of the WEFS was intensity. Individuals who score
high on this domain typically endorse experiencing distressing psychiatric symptoms at a
severe level within 1 week. The only exception is with the positive mental health factor,
in which high scores indicate a high intensity of protective factors, such as selfconfidence and optimism.
In order to test whether the intensity ratings of the WEFS demonstrated construct
validity and to further investigate the factor structure of the measures, a principal
components factor analysis with varimax rotation using the Kaiser criterion was
conducted. The 27 items from the WEFS were analyzed, and five factors with rotated
eigenvalues greater than 1 were extracted. Using the factor loading criterion of .40 or
higher for items in each factor, five factors were retained. This factor loading criterion
accounted for 70.91% of the total variance. Table 8 presents the description and
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distribution of items’ corresponding factors, along with each item’s factor loading. A
KMO statistic was found to be strong (KMO = 0.867), suggesting that the inter-item
correlations are relatively compact, and thus, the factor analysis should yield distinct and
reliable factors. Also, the Bartlett’s test of sphericity was found to be significant (p <
.0001). The significance suggests that each item correlates significantly with other items
and a factor analysis is appropriate for this dataset.
Items that loaded uniquely to one factor were included; therefore, items that
loaded on two or more factors were omitted unless otherwise noted. Additionally,
individual factors with only one or two items were discarded and not interpretable,
leaving three interpretable factors. Results indicate that items that loaded on individual
factors closely reflect three of the five hypothesized factors: Positive Mental Health,
Anxiety and Depression, and Anger.
Factor 1, Positive Mental Health, included 10 items. Individuals who score high
on this factor endorse experiencing a high level of protective factors. This factor included
a combination of items that described positive mental health, including content, selfconfident, optimism, worthwhile, connected to others, adequate/good enough, in control
of my emotions, interesting, attractive, and grateful. These items generally reflect the
degree to which individuals feel positively about themselves. All items loaded onto this
factor.
Factor 2, Anxiety and Depression, included six items. Individuals who score high
on this factor endorse experiencing a high level of distressing symptoms related to
clinical anxiety and depression. This factor included a combination of items that
described psychological distress, such as anxiety and depressive symptoms, including
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worried, afraid/scared, restless, overwhelmed, sad, and hopelessness/helplessness. These
items generally reflect the degree to which individuals experience psychological distress.
This factor combined two factors, Anxiety and Depression, but did not include such items
as ashamed, guilty, lonely, and apathetic.
Factor 3, Anger, included three items. Individuals who score high on this factor
endorse experiencing a high level of anger. This factor included a combination of items
that described anger, including annoyed, bitter, and angry. These items generally reflect
the degree to which individual experience the emotion, anger. The items that did not load
on this factor were frustrated and hostile.
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Table 8
WEFS Intensity Factor Loadings
Factor 4:

Positive Mental Health

Item

Loading

Item 16: Content

0.839

Item 17: Self-confident

0.880

Item 18: Optimistic

0.894

Item 19: Worthwhile

0.895

Item 20: Connected to others

0.845

Item 21: Adequate/Good enough

0.845

Item 22: In control of my emotions

0.755

Item 23: Interesting

0.828

Item 24: Attractive

0.836

Item 25: Grateful

0.806

Factor 2:

Anxiety & Depression

Item

Loading

Item 1: Worried

0.871

Item 2: Afraid/Scared

0.679

Item 3: Restless

0.769

Item 4: Overwhelmed

0.757
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Item 6: Sad

0.733

Item 10: Hopeless/helpless

0.610

Factor 3:

Anger

Item

Loading

Item 11: Annoyed

0.777

Item 12: Bitter

0.708

Item 14: Angry

0.850

Note. WEFS = Weekly Emotional and Functional Summary.

Table 9 lists the eigenvalues and the percentage of variance explained by the
factors for the individual WEFS Intensity factors using rotation sums of squared loadings.
The percentages of variance, as well as the cumulative percentage variance, are presented
for each factor.
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Table 9
Eigenvalues and Explanation of Variance by WEFS Intensity Factor
Factor

Eigenvalues

% of variance

Cumulative %

1

7.266

26.911

26.911

2

4.414

16.348

43.260

3

3.271

12.114

55.373

Note. WEFS = Weekly Emotional and Functional Summary.

WEFS Intensity Coefficient Alpha Reliability
To investigate the internal consistency reliability of the WEFS, a total scale
estimate of internal reliability was calculate using Cronbach’s coefficient alpha. Also,
domain estimates of internal consistency were calculated for each factor. Coefficient
alpha data for the total scale and each factor are listed in Table 10.
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Table 10
Coefficient Alpha Reliability for Individual WEFS Intensity Factors
Factor

Description

Coefficient Alpha

1

Positive Mental Health

0.955

2

Anxiety & Depression

0.889

3

Anger

0.848

Total WEFS Intensity Scale Coefficient Alpha = 0.893
Note. WEFS = Weekly Emotional and Functional Summary.

Factor Analysis of WEFS Functioning
The third analyzed domain of the WEFS was frequency. Individuals who score
high on this domain typically endorse meeting expectations and functioning at home, at
the workplace, and with others. Individuals who score low on this domain typically
endorse functional impairments.
In order to test whether the functioning domain of the WEFS demonstrated
construct validity and to further investigate the factor structure of the measures, a
principal components factor analysis with varimax rotation was conducted. The seven
items from the WEFS Functioning domain were analyzed separately because a separate
rating scale (0-10) was used. Using the factor loading criterion of .40 and more for items
in each factor, one factor was retained, accounting for 55.58% of the total variance. Table
11 presents the description and distribution of items’ corresponding factors, along with
each item’s factor loading. A KMO statistic was found to be strong (KMO = 0.848),
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suggesting that the inter-item correlations are relatively compact, and thus, the factor
analysis should yield distinct and reliable factors. Also, the Bartlett’s test of sphericity
was found to be significant (p < .0001). The significance suggests that each item
correlates significantly with other items and a factor analysis is appropriate for this
dataset.
In regard to individual factors, only items that loaded uniquely to one factor were
included; therefore, items that loaded on two or more factors were omitted unless
otherwise noted. Results indicate that items that loaded on individual factors closely
reflect one of the one hypothesized factor: Functioning.
Factor 1, Functioning, included seven items. Individuals who score high on this
factor endorse meeting expectations placed upon them in the workplace, at home, and in
relationships with others. This factor included a combination of items that described
overall functioning in multiple areas of life, including relationships at home,
responsibilities at home, relationship with friends, relationship with
coworkers/classmates, performance at work/school, use of leisure time, and overall
physical health. Lower scores on these items generally indicate the degree to which
individuals feels they are functionally impaired because of their mental health symptoms.
Higher scores on these items generally indicate the degree to which individuals feel they
are functioning well. All hypothesized items loaded onto this factor.
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Table 11
WEFS Functioning Factor Loading
Factor 7:

Functioning

Item

Loading

Item 1: Relationships at home

0.661

Item 2: Responsibilities at home

0.712

Item 3: Relationships with friends

0.780

Item 4: Relationships with coworkers/classmates

0.744

Item 5: Performance at work/school

0.761

Item 6: Use of your leisure time

0.821

Item 7: How do you feel physically

0.728

Note. WEFS = Weekly Emotional and Functional Summary.

Table 12 lists the eigenvalue and the percentage of variance explained by the
factor for the individual WEFS Functioning factor using rotation sums of squared
loadings. The percentages of variance, as well as the cumulative percentage variance, are
presented for the factor.
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Table 12
Eigenvalue and Explanation of Variance by WEFS Functioning Factor
Factor

Eigenvalue

% of variance

Cumulative %

1

3.89

55.58

55.58

Note. WEFS = Weekly Emotional and Functional Summary.

WEFS Functioning Coefficient Alpha Reliability
To investigate the internal consistency reliability of the WEFS, a total scale
estimate of internal reliability was calculated using Cronbach’s coefficient alpha. Also,
domain estimates of internal consistency were also calculated for each factor. Coefficient
alpha data for the total scale and each factor are listed in Table 13.

Table 13
Coefficient Alpha Reliability for WEFS Functioning Factor
Factor

Description

Coefficient alpha

1

Functioning

0.865

Total WEFS Functioning Scale Coefficient Alpha = 0.865
Note. WEFS = Weekly Emotional and Functional Summary.
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Correlation of WEFS Factors
Pearson product-moment correlation coefficients were computed for each
relationship between factors. Table 14 presents the intercorrelations for each WEFS
factor. Pearson product-moment correlation coefficients for a majority of the factors were
significantly and positively correlated (p < .001). The correlation coefficients of those
factors that were significantly correlated ranged from -.502 to .729, suggesting strong
relationships between most factors. However, the relationships are not strong enough to
suggest multicollinearity, meaning each factor can be considered to measure its own
individual construct. Additionally, the intercorrelations between factors were in the
expected directions. Positive Mental Health was positively correlated with functioning
and negatively correlated with Anxiety, Anger, and Anxiety and Depression. Anxiety was
positively correlated with Anger and Anxiety and Depression and negatively correlated
with Positive Mental Health and Functioning. Anger was positively correlated with
Anxiety and Depression as well. Finally, Functioning was positively correlated with
Positive Mental Health but negatively correlated with Anxiety, Anger, and Anxiety and
Depression.
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Table 14
Pearson Intercorrelation Matrix of WEFS Factors

F1 (F)

r
p=

F2 (F)

r
p=

F3 (F)

r
p=

F1 (I)

r
p=

F2 (I)

r
p=

F3 (I)

r
p=

F1 (Fu)

r
p=

F1 (F)

F2 (F)

F3 (F)

F1 (I)

F2 (I)

F3 (I)

F1 (Fu)

1

-.502**
.000

-.380**
.000

.620**
.000

-.432**
.000

.245**
.000

.708**
.000

1

.533**
.000

-.316**
.000

.674**
.000

.422**
.000

-.472**
.000

1

-.321**
.000

.374**
.000

.729**
.000

-.382**
.000

1

.028
.733

.052
.525

.506**
.000

1

.583**
.000

-.315**
.001

1

-.211*
.035
1

Note. WEFS = Weekly Emotional and Functional Summary. F1 (F) = Positive Mental Health,
Frequency; F2 (F) = Anxiety, Frequency; F3 (F) = Anger, Frequency; F1 (I) = Positive Mental
Health, Intensity; F2 (I) = Anxiety, Intensity; F3 (I) = Anger, Intensity; F1 (Fu) = Functioning.
**p < .01, two-tailed. *p < .05, two-tailed.

Hypothesis 2
WEFS Construct Validity Analyses
To examine whether the WEFS factors correlated with previously established
measures in the respective areas, analyses using the Pearson product-moment coefficients
of correlation were conducted. However, because the factor structure obtained was
different from that hypothesized, adjustments were made. Therefore, the seven WEFS
factors obtained in the factor analysis were correlated to previously established measures
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in the respective areas, as opposed to the hypothesized factors.
WEFS Frequency Positive Mental Health Factor
It was hypothesized that the WEFS Positive Mental Health factor would be
negatively correlated with a standardized self-report measure of positive mental health
and well-being, including the well-being dimension of the Clinical Outcomes in Routine
Evaluation-Outcome Measure (CORE-OM), and positively correlated with the positive
affect subscale of the PANAS. This hypothesis was supported. Total scores on the WEFS
Frequency Positive Mental Health factor and the well-being dimension of the CORE-OM
were found to be significantly and negatively correlated, r(153) = -.781, p < .0001.
Additionally, total scores on the WEFS Frequency Positive Mental Health factor and the
positive affect subscale of the PANAS were found to be significantly and positively
correlated, r(145) = .711, p < .0001.
The results indicate that the more frequently individuals endorse positive mental
health characteristics on the WEFS, the less frequently they endorse deficits in their
positive mental health and well-being on a standardized measure. Additionally, the
results indicate that the more frequently individuals endorse positive mental health
characteristics on the WEFS, the more frequently they endorse positive affect
characteristics on a standardized measure. These results suggest strong construct validity
as demonstrated by -.781 and .711 correlations between the WEFS Frequency Positive
Mental Health factor and the well-being dimension of the CORE-OM and positive affect
subscale of the PANAS (Table 15).
Additional exploratory analyses revealed that the WEFS Frequency Positive
Mental Health factor was significantly and negatively correlated with measures of
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anxiety, anger, and depression (Table 15). However, these correlations were not as strong
as other relationships, suggesting that the presence of positive mental health may be a
related but ultimately independent concept. Additionally, the WEFS Frequency Positive
Mental Health factor was significantly and negatively correlated with a standardized
measure of deficits of functioning

(-.691), suggesting that cultivating positive

symptoms may relate to one’s ability to perform well in relationships and in
responsibilities (Table 15).
WEFS Frequency Anxiety Factor
It was hypothesized that the WEFS Anxiety factor would be positively correlated
with a standardized self-report measure of Anxiety, including the Beck Anxiety Inventory
(BAI); the PROMIS Emotional Distress Anxiety, Short Form; and the negative affect
subscale of the PANAS. This hypothesis was supported. Total scores on the WEFS
Frequency Anxiety factor and BAI were found to be significantly and positively
correlated, r(153) = .668, p < .0001. Total scores on the WEFS Frequency Anxiety factor
and the PROMIS Emotional Distress Anxiety, Short Form, were found to be significantly
and positively correlated, r(153) = .740, p < .0001. Additionally, total scores on the
WEFS Frequency Anxiety factor and the negative affect subscale of the PANAS were
found to be significantly and positively correlated, r(145) = .736, p < .0001.
The results indicate that the more frequently individuals endorse anxiety
symptoms on the WEFS, the more frequently they endorse anxiety symptoms on other
standardized measures. Additionally, the results indicate that the more frequently
individuals endorse anxiety symptoms on the WEFS, the more frequently they also
endorse experiencing negative affect characteristics. These results suggest strong
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construct validity as demonstrated by .668, .740, and .736 correlations between the
WEFS Frequency Anxiety factor and the BAI; the PROMIS Emotional Distress Anxiety,
Short Form; and the negative affect subscale of the PANAS (Table 15), respectively.
Additional exploratory analyses revealed that the WEFS Frequency Anxiety
factor was significantly and positively correlated with standardized measures of anger,
depression, and deficits in well-being and functioning (Table 15). However, correlations
between the WEFS Frequency Anxiety factor and standardized measures of depression
were the strongest of these, suggesting that the overlap between these diagnoses is
considerable.
WEFS Frequency Anger Factor
It was hypothesized that the WEFS Anger factor would be positively correlated
with a standardized self-report measure of anger, including the PROMIS Emotional
Distress Anger, Short Form and the negative affect subscale of the PANAS. This
hypothesis was supported. Total scores on the WEFS Frequency Anger factor and the
PROMIS Emotional Distress Anger, Short Form, were found to be significantly and
positively correlated, r(153) = .729, p < .0001. Total scores on the WEFS Frequency
Anger factor and the negative affect subscale of the PANAS were found to be
significantly and positively correlated, r(145) = .492, p < .0001.
The results indicate that the more frequently individuals endorse anger on the
WEFS, the more frequently they endorse anger on other standardized measures.
Additionally, the results indicate that the more frequently individuals endorse anger on
the WEFS, the more frequently they also endorse experiencing negative affect
characteristics. These results suggest strong construct validity, as demonstrated by .729
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and .492 correlations between the WEFS Frequency Anger factor and the PROMIS
Emotional Distress Anger, Short Form, and the negative affect subscale of the PANAS
(Table 15).
Additional exploratory analyses revealed that the WEFS Frequency Anger factor
was significantly and positively correlated with standardized measures of anxiety,
depression, and deficits in well-being and functioning (Table 15). The significance may
suggest that anger is commonly related to anxiety and depressive symptoms, such that it
may underlay these symptoms.

WEEKLY EMOTIONAL AND FUNCTIONAL SUMMARY

72

Table 15
Pearson Correlation Matrix of WEFS Frequency Factors & Standardized Measures
Measure

F1 (F)

F2 (F)

F3 (F)

BAI

r
p=

-.362**
.000

.740**
.000

.430**
.000

PROMIS Emotional Distress Anxiety,
Short Form

r
p=

-.424**
.000

.740**
.000

.385**
.000

PROMIS Emotional Distress Anger,
Short Form

r
p=

-.404**
.000

.377**
.000

.729**
.000

PROMIS Severity Measure Depression,
Adult

r
p=

-.590**
.000

.660**
.000

.495**
.000

QIDS-SR

r
p=

-.583**
.000

.675**
.000

.464**
.000

Positive Affect (PANAS)

r
p=

.711**
.000

-.404**
.000

-.275**
.000

Negative Affect (PANAS)

r
p=

-.583**
.000

.736**
.000

.492**
.000

Well-being (CORE-OM)

r
p=

-.781**
.000

.657**
.000

.507**
.000

Functioning (CORE-OM)

r
p=

-.691**
.000

.588**
.000

.585**
.000

Note. Weekly Emotional and Functional Summary (WEFS), Beck Anxiety Inventory (BAI),
Patient-Reported Outcomes Measurement Information System (PROMIS), Positive Affect and
Negative Affect Scale (PANAS), Clinical Outcomes in Routine Evaluation – Outcome Measure
(CORE-OM). Bolded items signify correlations calculated for specific hypotheses noted in text.
F1 (F) = Positive Mental Health, Frequency; F2 (F) = Anxiety, Frequency; F3 (F) = Anger,
Frequency. ** p < .01, two-tailed. * p < .05, two-tailed.

WEFS Intensity Positive Mental Health Factor
It was hypothesized that the WEFS Positive Mental Health factor would be
negatively correlated with a standardized self-report measure of positive mental health
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and well-being, including the well-being dimension of the CORE-OM, and positively
correlated with the positive affect subscale of the PANAS. This hypothesis was
supported. Total scores on the WEFS Frequency Positive Mental Health factor and the
well-being dimension of the CORE-OM were found to be significantly and negatively
correlated, r(151) = -.487, p < .0001. Additionally, total scores on the WEFS Frequency
Positive Mental Health factor and the positive affect subscale of the PANAS were found
to be significantly and positively correlated, r(143) = .458, p < .0001.
The results indicate that the higher individuals endorse positive mental health
characteristics on the WEFS, the less they endorse deficits in their positive mental health
and well-being on a standardized measure. Additionally, the results indicate that the
higher individuals endorse positive mental health characteristics on the WEFS, the more
they endorse positive affect characteristics on a standardized measure. These results
suggest strong construct validity, as demonstrated by -.487 and .458 correlations between
the WEFS Frequency Positive Mental Health factor and the well-being dimension of the
CORE-OM and positive affect subscale of the PANAS (Table 16).
Additional exploratory analyses revealed that the WEFS Intensity Positive Mental
Health factor was significantly and negatively correlated with standardized measures of
anxiety, anger, depression, and deficits in well-being and functioning (Table 16). These
results were similar to those of the WEFS Frequency Positive Mental Health factor, such
that these correlations were not as strong as other relationships, possibly suggesting that
the severity of positive mental health may be a related but independent topic to address in
mental health treatment. The significant and negative correlation supports an inverse
relationship; however, the strength of the relationship may support previous research that
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shows solely focusing on the alleviation of symptoms does not equate to the presence of
positive mental health.
WEFS Intensity Anxiety and Depression Factor
It was hypothesized that the WEFS Anxiety factor would be positively correlated
with standardized self-report measures of anxiety, including the BAI; the PROMIS
Emotional Distress Anxiety, Short Form; and the negative affect subscale of the PANAS.
However, it was also hypothesized that the WEFS Depression factor would be positively
correlated with standardized self-report measures of depression, including the Quick
Inventory of Depressive Symptomatology – Self Report (QIDS-SR), the PROMIS
Severity Measure for Depression, Adult, and the negative affect subscale of the PANAS.
This hypothesis was supported. These two hypotheses were combined when calculating
correlations for this factor because both anxiety and depression items loaded onto this
factor.
First, total scores on the WEFS Intensity Anxiety and Depression factor and BAI
were found to be significantly and positively correlated, r(150) = .559, p < .0001.
Second, total scores on the WEFS Intensity Anxiety and Depression factor and the
PROMIS Emotional Distress Anxiety, Short Form, were found to be significantly and
positively correlated, r(150) = .604, p < .0001. Third, total scores on the WEFS Intensity
Anxiety and Depression factor and the negative affect subscale of the PANAS were
found to be significantly and positively correlated, r(142) = .623, p < .0001. Fourth, total
scores on the WEFS Intensity Anxiety and Depression factor and the QIDS-SR were
found to be significantly and positively correlated, r(150) = .552, p < .0001. Finally, total
scores on the WEFS Intensity Anxiety and Depression factor and the PROMIS Severity
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Measure for Depression, Adult, were found to be significantly and positively correlated,
r(150) = .607, p < .0001.
The results indicate that the more severe individuals endorse anxiety and
depressive symptoms on the WEFS, the more they endorse anxiety and depression
symptoms on other standardized measures. Additionally, the results indicate that the
more severe individuals endorse anxiety and depressive symptoms on the WEFS, the
more they also endorse experiencing negative affect characteristics on other standardized
measures. These results suggest strong construct validity, as demonstrated by .559, .604,
.623, .552, and .607 correlations between the WEFS Intensity Anxiety and Depression
factor and the BAI; the PROMIS Emotional Distress Anxiety, Short Form; the QIDS-SR;
the PROMIS Severity Measure of Depression, Adult; and the negative affect subscale of
the PANAS, respectively (Table 16).
Additional exploratory analyses revealed that the WEFS Intensity Anxiety factor
was significantly and positively correlated with standardized measures of anger and
deficits in well-being and functioning (Table 16). These results were similar to the WEFS
Frequency Anxiety factor and revealed that the severity of anxious and depressive
symptoms is correlated with anger and that the symptoms are more strongly related to
deficits in well-being and functioning. These results may suggest that the more severely
anxious or depressed individuals are, the less likely they are to experience positive mental
health symptoms and perform well with responsibilities or relationships. These results
aligns well with the literature regarding functional impairments that mental health
disorders cause.
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WEFS Intensity Anger Factor
It was hypothesized that the WEFS Anger factor would be positively correlated
with a standardized self-report measure of anger, including the PROMIS Emotional
Distress Anger, Short Form, and the negative affect subscale of the PANAS. This
hypothesis was supported. Total scores on the WEFS Intensity Anger factor and the
PROMIS Emotional Distress Anger, Short Form, were found to be significantly and
positively correlated, r(151) = .630, p < .0001. Total scores on the WEFS Intensity
Anger factor and the negative affect subscale of the PANAS were found to be
significantly and positively correlated, r(143) = .459, p < .0001.
The results indicate that the more severe individuals endorse anger on the WEFS,
the more they endorse anger on other standardized measures. Additionally, the results
indicate that the more severe individuals endorse anger on the WEFS, the more they also
endorse negative affect characteristics. These results suggest strong construct validity, as
demonstrated by .630 and .459 correlations between the WEFS Intensity Anger factor
and the PROMIS Emotional Distress Anger, Short Form, and the negative affect subscale
of the PANAS, respectively (Table 16).
Additional exploratory analyses revealed that the WEFS Intensity Anger factor
was significantly and positively correlated with standardized measures of anxiety,
depression, and deficits in well-being and functioning (Table 16). As mentioned with the
WEFS Frequency Anger factor, these results further suggests that the more severe
anxious or depressive symptoms are, the more likely an individual is to experience anger
or irritability. These results may be the result of low frustration tolerance from combating
mental illness symptoms or of poor emotion regulation strategies.
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Table 16
Pearson Correlation Matrix of WEFS Intensity Factors & Standardized Measures
Measure

F1 (I)

F2 (I)

F3 (I)

BAI

r
p=

-.262**
.001

.559**
.000

.392**
.000

PROMIS Emotional Distress Anxiety,
Short Form

r
p=

-.211**
.009

.604**
.000

.369**
.000

PROMIS Emotional Distress Anger,
Short Form

r
p=

-.296**
.000

.289**
.000

.630**
.000

PROMIS Severity Measure Depression,
Adult

r
p=

-.376**
.000

.607**
.000

.434**
.000

QIDS-SR

r
p=

-.355**
.000

.552**
.000

.409**
.000

Positive Affect (PANAS)

r
p=

.458**
.000

-.416**
.000

-.208*
.013

Negative Affect (PANAS)

r
p=

-.314**
.000

.623**
.000

.459**
.000

Well-being (CORE-OM)

r
p=

-.487**
.000

.610**
.000

.430**
.000

Functioning (CORE-OM)

r
p=

-.462**
.000

.509**
.000

.516**
.000

Note. Weekly Emotional and Functional Summary (WEFS), Beck Anxiety Inventory (BAI),
Patient-Reported Outcomes Measurement Information System (PROMIS), Positive Affect and
Negative Affect Scale (PANAS), Clinical Outcomes in Routine Evaluation – Outcome Measure
(CORE-OM). Bolded items signify correlations calculated for specific hypotheses noted in text.
F1 (I) = Positive Mental Health, Intensity; F2 (I) = Anxiety & Depression, Intensity; F3 (I) =
Anger, Intensity. ** p < .01, two-tailed. *p < .05, two-tailed.
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WEFS Functioning Factor
It was hypothesized that the WEFS Functioning factor would be negatively
correlated with a standardized self-report measure of functioning, including the
functioning dimension of the CORE-OM. Total scores on the WEFS Functioning factor
and the functioning dimension of the CORE-OM were found to be significantly and
negatively correlated, r(102) = -.699, p < .0001.
The results indicate that the higher individuals endorse positive functioning in
various areas of life on the WEFS, the less they endorse deficits in functional
impairments on a standardized measure. These results suggest strong construct validity,
as demonstrated by a -.699 correlation between the WEFS Functioning factor and the
functioning dimension of the CORE-OM (Table 17).
Additional exploratory analyses revealed that the WEFS Functioning factor is
significantly and negatively correlated with standardized measures of anxiety, anger,
depression, and deficits in well-being (Table 17). This finding provides support for
diagnostic purposes that mental illness symptoms are commonly associated with
functional impairments in responsibilities and relationships.
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Table 17
Pearson Correlation Matrix of WEFS Functioning Factor & Standardized Measures
Measure

F1 (Fu)

BAI

r
p=

PROMIS Emotional Distress Anxiety, Short Form

r
p=

-.311**
.001

PROMIS Emotional Distress Anger, Short Form

r
p=

-.405**
.000

PROMIS Severity Measure Depression, Adult

r
p=

-.641**
.000

QIDS-SR

r
p=

-590**
.000

Positive Affect (PANAS)

r
p=

.670**
.000

Negative Affect (PANAS)

r
p=

-.365**
.000

Well-being (CORE-OM)

r
p=

-.649**
.000

Functioning (CORE-OM)

r
p=

-.699**
.000

-.262**
.000

Note. Positive Affect and Negative Affect Scale (PANAS), Clinical Outcomes in Routine
Evaluation – Outcome Measure (CORE-OM). Bolded items signify correlations calculated for
specific hypotheses noted in text. F1 (Fu) = Functioning. ** p < .01, two-tailed. * p < .05, twotailed.
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Hypothesis 3
Test-Retest Reliability
Test-retest reliability was calculated for the WEFS by correlating the test and the
retest total scores from the time of intake and 1 week following to evaluate the reliability
of the WEFS over time. More specifically, test-retest reliability was calculated for the
following WEFS domains: Frequency, Intensity, and Functioning. Additionally,
dependent groups t tests were calculated for each domain, as well to assess for significant
differences between the means.
The test-retest correlation for the WEFS Frequency of .720 was high (p < .0001),
indicating strong reliability. The first-session mean WEFS Frequency total score of 45.73
(SD = 10.74) and the second-session mean WEFS Frequency total score of 44.73 (SD =
10.09) were comparable, and the means were not significantly different, t(53) = 1.178, p
< .244. The test-retest correlation for the WEFS Intensity of .428 was moderate (p <
.002), which does not meet the acceptance cutoff of .70. The first-session mean WEFS
Intensity total score of 87.14 (SD = 35.32) and the second-session mean WEFS Intensity
total score of 92.10 (SD = 36.54) were comparable, and the means were not significantly
different, t(50) = 1.448, p < .154. The test-retest correlation for the WEFS Functioning of
.860 was high (p < .0001), indicating strong reliability. The first-session mean WEFS
Functioning total score of 42.12 (SD = 13.93) and the second-session mean WEFS
Functioning total score of 45.63 (SD = 12.44) were comparable, and the means were
significantly different, t(30) = -2.533, p < .017.
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CHAPTER 5: DISCUSSION
Interpretation and Implication
The present study was conducted to evaluate the psychometric properties and the
factor structure of the Weekly Emotional and Functional Summary (WEFS; Salas, 2018).
This study sought to address the following: (a) to evaluate the factor structure of the selfreport measure, (b) to examine the validity of the WEFS factors by studying the
relationship between each factor and standardized measures with strong psychometric
properties, and (c) to assess the measure’s stability over time.
Psychometric Properties of the WEFS Factors
The WEFS is composed of three domains: Frequency, Intensity, and Functioning.
The WEFS was developed with these three domains to comprehensively measure mental
health symptoms, positive mental health characteristics, and functional impairments. A
principal components factor analysis was conducted for each domain because of
categorical distinctiveness and differences in rating scales. The first hypothesis related to
factor structure was partially supported, as the frequency and intensity domains revealed
three of the five hypothesized factors. The second hypothesis related to construct validity
was fully supported in each domain. The third hypothesis related to test-retest reliability
was also fully supported in each domain. In summary, the WEFS has a factor structure
that includes clinical symptoms commonly seen in outpatient mental health settings, such
as anxiety, depression, and anger, as well as positive mental and functional impairments.
The predicted correlations were in the expected directions of the hypotheses, lending
support to the construct validity of the WEFS. It appears to be internally consistent, as
shown by the scale coefficient alpha scores for each domain.
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WEFS Frequency Factors
The factor analysis conducted with the frequency domain revealed three
interpretable factors: Positive Mental Health, Anxiety, and Anger. The Positive Mental
Health factor measures how often an individual experiences positive affect and protective
factors, such as optimism, self-confidence, and connectedness to others. The Anxiety
factor measures how often an individual experiences anxious symptoms, such as worry
and restlessness. The Anger factor measures how often an individual experiences the
emotion of anger. Intercorrelations were in the expected directions, such that anxiety and
anger were significantly and negatively correlated with positive mental health and
significantly and positively correlated with one another.
Additionally, correlations with other standardized measures were in the expected
directions. The Positive Mental Health factor was significantly and positively correlated
with a measure of positive affect and negatively correlated with a measure of deficits in
positive mental health and well-being. The Anxiety factor was significantly and
positively correlated with measures of anxiety and negative affect. The Anger factor was
significantly and positively correlated with measures of anger and negative affect. These
findings suggest that factors accurately exhibited convergent validity, meaning that the
items were closely related to measures in their respective areas. Test-retest reliability
results indicated that the Frequency domain was stable over time.
The results indicated that the hypothesized depression factor was not distinct or
strong enough to load on its own. The items loaded onto more than one factor, suggesting
an overlap and comorbidity between depressive symptoms and other mental health
concerns, such as anxiety and anger. Perhaps if individuals experience distressing mental
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health symptoms for a significant period of time, they are more likely to develop
depressive symptoms (e.g., hopelessness for success in treatment, sadness with their
levels of distress, feelings of loneliness from not being understood) regardless of meeting
clinical levels. These items also may be similar to other mental health symptoms.
Additionally, the results indicated that the hypothesized risk factor was not
distinct or strong enough to load on its own. After further consideration, this result
appeared to be due to content differences, such that the correlation between homicidality
and suicidality is minimal, although this result is still important to assess routinely.
WEFS Intensity Factors
The factor analysis conducted with the intensity domain revealed three
interpretable factors: Positive Mental Health, Anxiety and Depression, and Anger. The
Positive Mental Health factor measures the strength of an individual’s positive affect and
protective factors, such as optimism, self-confidence, and connectedness to others. The
Anxiety factor measures the severity of anxiety an individual experiences, such as worry
and restlessness. The Anger factor measures the severity of anger an individual
experiences. Intercorrelations were in the expected directions, such that anxiety and
depression and anger were significantly and negatively correlated with positive mental
health and significantly and positively correlated with one another.
Additionally, correlations with other standardized measures were also in the
expected directions. The Positive Mental Health factor was significantly and positively
correlated with a measure of positive affect and negatively correlated with a measure of
deficits in positive mental health and well-being. The Anxiety and Depression factor was
significantly and positively correlated with measures of anxiety, depression, and negative
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affect. The Anger factor was significantly and positively correlated with measures of
anger and negative affect. These findings suggest that factors accurately exhibited
convergent validity, meaning that the items were closely related to measures in their
respective areas. Test-retest reliability results indicated that the Intensity domain was
stable over time.
The results indicated that the hypothesized depression factor was not distinct
enough to load on its own and rather overlapped significantly with anxiety. Although this
result was not hypothesized, the factor loading is understandable because of the close
relationship between anxiety and depressive disorders. Similar to the frequency domain,
the results indicated that the hypothesized risk factor was not distinct or strong enough to
load on its own. As previously mentioned, this result also appeared to be the result of
content differences, such that the correlation between homicidality and suicidality may be
minimal. The factor structures of the frequency and intensity domains were similar. This
result suggests that these factors exhibit strong psychometric properties and accurately
measure distressing mental health symptoms, as well as positive mental health.
WEFS Functioning Factor
The factor analysis conducted with the Functioning domain revealed one cohesive
interpretable factor. The Functioning factor measures how well an individual meets
demands at home, school, work, and in relationships. The Functioning factor was
significantly and negatively correlated with a standardized measure of functional
impairment.
Test-retest reliability results indicated that the Functioning domain was stable
over time, but that there were significant differences between the means at the p < .01
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level. This result may suggest that an individual’s functioning increases slightly after the
intake appointment because of hope in the treatment plan and normalization of symptoms
(Irving et al., 2004). Hope may enhance motivation to approach tasks, as an individual
perceives less helplessness (Irving et al., 2004). Another possibility may be that
functioning scores increased if the therapist provided behavioral activation or an active
homework assignment to engage the client in the treatment plan. Behavioral activation is
engaging but does not lead to an immediate fluctuation in symptoms (Barlow, 2014).
Exploratory Analyses
Ancillary analyses were conducted when examining the psychometric properties
of the WEFS. These analyses were not based on hypotheses, should be evaluated with
caution, and should be studied with an independent sample. Given the number of
analyses conducted, these results may capitalize on chance. These findings were noted in
Chapter 4 and appear to align well with previous literature in the respective areas. First,
the WEFS Positive Mental Health factor for both frequency and intensity domains was
significantly and negatively correlated with the WEFS Anxiety, Anger, and Anxiety and
Depression factors, as well as with standardized measures of anxiety, depression, and
anger. However, these correlations were not as strong as other relationships. This result
suggests that the presence and strength of positive mental health is related to negative
symptoms but is ultimately an independent concept. This finding aligns with research
conducted on the dual-factor model of positive mental health and psychopathology, such
that eliminating negative symptoms does not automatically equate to positive mental
health (Greenspoon & Saklofske, 2001; Lukat et al., 2016; Trompetter et al., 2017).
Additionally, positive mental health should be routinely assessed because it may function
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as a protective factor against relapse of mental health symptoms by aiding in problemsolving abilities, enhancing resiliency, processing adversity, and regulating emotions
(Frederickson, 2013; Teismann et al., 2018; Tugade & Frederickson, 2004).
Next, the WEFS Anxiety factors for both frequency and intensity domains were
significantly and positively correlated with the WEFS Anger and Anxiety and Depression
factors, as well as with standardized measures of depression and anger. However,
correlations between the WEFS Frequency Anxiety factor and standardized measures of
depression were the strongest correlations. This result aligns with previous research
suggesting that anxiety and depression diagnoses are highly comorbid and that symptoms
overlap considerably (Fava et al., 2000).
Additionally, the WEFS Anger factors for both frequency and intensity domains
were significantly and positively correlated with the WEFS Anxiety and Anxiety and
Depression factors, as well as with standardized measures of anxiety and depression. This
finding supports previous research indicating that anger underlies many mental health
concerns (Cella et al., 2010). Anger has been strongly correlated with an increased
physiological arousal, which may put an individual at a higher risk for stress-related
diseases (Suls & Bunde, 2005). Furthermore, unrecognized anger can lead to depressive
symptoms, feelings of guilt, anxious symptoms, passive aggressiveness, and resentment
toward others, further supporting the necessity of assessment of anger in mental health
settings (Kopper & Epperson, 1996).
Finally, the WEFS Functioning factor was significantly and negatively correlated
with the WEFS Anxiety, Anger, and Anxiety and Depression factors, as well as with
standardized measures of anxiety, anger, and depression. This finding suggests that the
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WEFS may accurately assess for functional impairments in symptomatic populations.
Individuals with mental health disorders often experience difficulties meeting
expectations placed upon them in the workplace, at school, and in relationships.
Clinical Utility of the WEFS
According to research conducted on the development and construction of
psychological tests, a self-report measure must adequately sample or assess the concept
under consideration, exhibit standardization, display normed values that show a
distribution, demonstrate objectivity, and somehow have impact on or benefit others
(Aiken, 1998). Additionally, self-report measures are deemed useful if they exhibit
objectivity, are quantifiably measured, comprise scores that communicates meaning,
support the economy of time, are standardized, and are generalizable or provide external
validity (Aiken, 1998). Utility of a self-report measure, including comparative and
clinical utility, assesses the value of a scale, such that it is as useful as or more useful than
a similar test and that it provides additional diagnostic assessment or treatment
information (Cohen et al., 2013). More specifically, clinical utility is measured by
assessing psychometric soundness, costs, and benefits (Cohen et al., 2013). The current
study of the WEFS was preliminary. While further investigation of the measure is
needed, the results of this preliminary study provide promising consideration to the utility
of the measure and its ability to address a specific need for a comprehensive, yet
consolidated, self-report measure for clinical purposes.
The results of the study support that the WEFS adequately measures common
presenting problems, including anxiety, anger, positive mental health, and functioning, in
outpatient mental health settings. The results of the study indicate the WEFS’s depression
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items would benefit from further development and investigation. Currently, the measure
appears to exhibit standardization, display objectivity through quantifiable measurements,
and impact others by offering a cost-effective and efficient measure that is approachable
in terms of administration and scoring. Additionally, scores on the WEFS factors
demonstrate meaning, such that a higher score in the Anxiety factor may be interpreted as
more severe anxiety. The items of the measure are often a single word or symptom for
ease of completion.
In terms of psychometric characteristics, the WEFS appears to exhibit stability
over time and a cohesive factor structure, as well as aspects of construct and content
validity. Additionally, the benefits of the WEFS are believed to outweigh the costs in
economic and noneconomic terms. For example, the measure provides a wealth of
information at a low economic and time cost. The measure is also easy to administer and
understand because the items are common symptoms and organized by domain and
factor.
At this time, the WEFS is believed to be a unique and useful alternative to
existing outcome self-report measures. It is comprehensive in content (i.e., diagnostic
symptoms, protective factors and quality of life, and functional impairments), is inclusive
in the assessment of the content (i.e., frequency and intensity of symptoms), and is
succinct in fashion. As the results of the study demonstrate, the WEFS appears to
adequately assess common presenting problems in outpatient mental health settings and
measure other psychological characteristics, such as positive mental health, that have
been shown to enhance functioning and quality of life.
To review, the literature on self-report questionnaires states that clinicians who
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incorporate reliable and valid clinical tools in their practice improve their accuracy of
diagnosing and the efficacy of treatment (Bar-Kalifa et al., 2016; Hannan et al., 2005;
Wolfe & Pincus, 1999; Zimmerman et al., 2018). Treatment protocols also typically
recommend the use of self-report measures for improved accuracy in diagnosing and for
routine use in monitoring treatment progress (APA, 2010; Harding et al., 2011; National
Collaborating Centre for Mental Health, 2009; Peterson & Fagan, 2017; Trivedi et al.,
2006; Zimmerman et al., 2018). Quantitative and objective measurements demonstrate
progress through treatment in a standardized way that can be used for comparison
purposes with precision (Lambert et al., 2001; Lambert et al., 2002; Lambert, Hansen, &
Finch, 2001; Nezu et al., 2000; Prescott et al., 2017; Wolfe & Pincus, 1999; Zimmerman
et al., 2008; Zimmerman et al., 2018).
The literature on the usefulness of self-report measures may appear
straightforward. However, questionnaires are commonly underutilized in clinical practice
because clinicians do not want to burden their patients each week with extensive
paperwork (Peterson & Fagan, 2017). To date, self-report measures assess only one or
two areas and are either lengthy for patients to complete or lengthy for clinicians to score.
Research shows that if a routine outcome measure is not parsimonious, it will likely be
underutilized as a clinical tool of measurement (Peterson & Fagan, 2017).
Underutilization of routine self-report measures may lead to inaccurate assumptions
regarding the patient’s functional impairments or current level of distress (Fayers &
Machin, 2013; Wolfe & Pincus, 1999; Zimmerman et al., 2018). The value of self-report
measures cannot be overlooked in clinical practice, as they have been shown to increase
efficacy of treatment (Zimmerman et al., 2008; Zimmerman et al., 2018) and are
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efficient, systematic, standardized (Wolfe & Pincus, 1999), as well as cost-effective, tools
(Garfield et al., 2011). The WEFS attempts to address these obstacles to routine outcome
measuring.
To address efficiency, the WEFS assesses seven factors in 34 items, as opposed to
similar standardized measures in each factor totaling 90 items. The WEFS was
purposefully designed for patients to quickly read and rate symptoms rather than to try to
understand wordy items. The WEFS is also organized by factor. The organization
provides simple administration and allows the clinician to score and interpret quickly.
The organization of the scale also increases the efficiency, effectiveness, and practicality
of the measure without compromising crucial data needed for tracking progress.
In terms of cost effectiveness, the WEFS is one measure that assesses many
variables, including common diagnostic symptoms seen in mental health settings, as well
as positive mental health and functioning. The benefits of using one scale for routine
outcome measuring include simplicity for both patient and clinician, an additional source
of data for documentation and treatment progress, efficiency of gathering data in multiple
areas, and cost effectiveness of purchasing one measure as opposed to many. For
example, a self-report measure outside of the public domain, such as the Beck Anxiety
Inventory (BAI; Beck et al., 1988; Beck & Steer, 1990), costs approximately $2.47 for
each use. If clinicians were to routinely assess anxiety symptoms in 20 to 30 patients a
week, they would spend $49.44 to $74.10 per week to measure one domain. At
maximum, if a patient was in therapy for a year and measured weekly as recommended,
the total cost would be $3,848.00.
If used in clinical practice, a patient would complete the self-report measure
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before the intake appointment to provide baseline information. During the intake
appointment, the clinician would review the scores with the patient and explain the
meaning of these scores while reflecting back to the patient for accuracy. If the directions
were unclear to the patient, the clinician would review the difference between a
frequency rating and an intensity rating. The patient would also be asked to arrive at the
office approximately 10 minutes early for each session in order to complete the measure
beforehand. The clinician would keep the completed measures in the patient’s file, noting
the date and session number to appropriately track progress. Scores could be added to the
patient’s progress note and used as an effective tool in comparing progress and even
setbacks for informing treatment goals, agenda setting, and supporting growth.
Although this study is preliminary, the results suggest that the WEFS is a valuable
measure. It may be used in clinical settings to assess patients’ frequency and intensity of
symptoms in the following factors: Anxiety, Anxiety and Depression, Anger, Positive
Mental Health, and Functioning. Furthermore, these results suggest that the WEFS is a
standardized measure that can potentially be used to aid in collaboration, inform
treatment, measure progress outcomes, increase the efficacy of treatment, assess
treatment goals, and evaluate current level of functioning to assess improvement over
time. The WEFS assesses various clinical domains and includes critical aspects to patient
care that are often overlooked, such as positive mental health and how symptoms impair
functioning. As an added value from a cognitive-behavioral approach, the WEFS also
includes agenda setting and feedback, in a brief and consolidated manner, to enhance
efficiency for time in the session to be spent on therapeutic interventions. These results
contribute to the usefulness of the WEFS in clinical practice and provide a welcome
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alternative to measuring treatment progress.
Limitations
The findings from the present study have limitations regarding the demographic
information of the sample, the setting in which the sample was gathered, and the
geographical location. The present study assessed willing participants who were seeking
an intake evaluation at an outpatient mental health center in northeastern Pennsylvania.
As the sample was predominantly composed of European American participants, it was
not as representative as the researchers had hoped, thereby limiting the generalizability of
the findings. The outpatient setting, measurements from one geographical location, and
lack of a controlled nonsymptomatic sample may limit the findings as well. Additionally,
some participants did not complete the measures entirely, leading to varied sample sizes
in the correlations to standardized measures.
There was a significantly smaller sample size for test-retest reliability. A sample
size may have been the result of patients not attending their follow-up appointments,
patients not completing the scale a second time, or perhaps clinicians forgetting to submit
the scale a second time to the researchers. Test-retest results are limited because of the
small sample size. Future research may focus more heavily on the reliability of the
measure to fully assess measurement sensitivity and stability over time.
Potential confounding variables that would threaten the strength of the internal
validity of the measure may be some participants completing measures quickly without
thinking through each question because of the amount of paperwork to complete at the
first appointment. In addition, participants might have completed the self-report with the
help of a family member or close friend in the waiting room, potentially confounding
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their true answers. Perhaps some participants did not understand the distinction between
frequency and intensity ratings while completing the scale in the waiting room before
having had the opportunity to discuss the measure with the clinician.
Additionally, social desirability could have influenced the way some participants
completed the measures, such that they may have wanted to please their clinician. Some
may not have felt comfortable completing the measures with honesty until establishing a
trusting relationship with their clinician. The self-report measures chosen were face valid,
and therefore, participants could have easily understood the purpose of the measure or the
content it was assessing. If participants were not comfortable sharing information, they
could have easily disguised their answers by responding more favorably (e.g., rating
symptoms lower than they were). Although the effects of social desirability may not have
negatively impacted the factor structure or validity analyses, it could impact the
generalizability and usefulness of the study and measure. However, just as vulnerability
is necessary for treatment to be effective, honesty in reporting symptoms is as well. These
limitations may be considered when understanding the utility of the measure and adapting
its use to each patient. Finally, some individuals failed to complete all of the items of the
measure and therefore were not included in the sample. The researcher did not investigate
specific characteristics, such as diagnoses, of those who omitted items. Therefore, not
completing all items of the measure is another limitation of the study to be investigated in
future research.
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Future Directions
Future research with the WEFS may further assess the factor structure and the
psychometric properties of the measure in different clinical settings (e.g., primary care,
inpatient, or residential programs) and geographical locations. Replicating the study with
a larger sample size, broader demographic variables, and even a control group could
further validate the psychometric properties of the WEFS for use with patients diverse in
clinical presentation, ethnicity, and cultural background. Additionally, future research
may explore the scores of participants with specific clinical presentations and diagnoses
on the measures and factors of the WEFS.
As Kline (2015) and Aiken (1998) described, self-report measures must provide
normed values for scores to be meaningful and comparable. Future research may focus on
further developing normed values of scores through the inclusion of a control
nonsymptomatic sample and through gathering larger samples to demonstrate a frequency
distribution of the scores and percentiles associated with each score.
Collecting data 4 weeks after the time of intake may provide a better estimate of
test-retest reliability. Such information may also be useful in further distinguishing the
Frequency domain from the Intensity domain as treatment progresses. It was
hypothesized that the participant scores would be relatively stable 1 week after the intake
appointment. The differentiation of the Frequency scores and Intensity scores over time
would be interesting to note as participants progress through treatment. Perhaps patterns
in severity of symptoms would decrease at a quicker rate than frequency of symptoms as
a result of the implementation of coping skills.
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Given the frequency of depressive disorders in outpatient mental health settings,
the development of a stable and distinct depression factor calls for further investigation.
Generating items that are unique to depression and do not overlap with anxiety or anger
would be important. For example, items on the Beck Depression Inventory (BDI-II; Beck
et al., 1996), such as past failures, loss of pleasure, self-dislike, self-criticism, and
worthlessness, were specifically designed and tested for discriminant validity with
anxiety. Therefore, only items that measured depression and not anxiety were included
and overlapping items were excluded when Beck and colleagues developed the 21-item
measure (Beck et al., 1996). Future research with the WEFS may choose to implement a
similar process to isolate items that create a cohesive and internally consistent depression
factor. Then, reassessment of construct validity and reliability would be needed. Perhaps
developing more items to assess risk factors for suicidal ideation apart from homicidal
ideation would be useful.
Additionally, the exploratory analyses conducted revealed many possibilities for
future research. For example, negative affect was significantly and positively correlated
with anxiety, anger, and anxiety and depression factors. Better understanding this
relationship and its difference from positive affect and trying to examine if one variable
or factor can predict the other would be interesting. Further research on negative affect
could be valuable in clinical settings to better understand the development of mental
illness and, from a cognitive-behavioral approach, the negative thinking patterns that are
revealed in a negative affect measure and their t relationship to specific diagnoses. A
relationship between negative affect and depression would appear to more likely be
stronger; however, the results of the study showed a stronger relationship between
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anxiety and negative affect than anxiety and depression with negative affect (Table 14).
Further exploring this relationship may help clinicians to better understand and detect
how negative affect relates to diagnostic presentations.
Another area of study could be to further assess the slight increase in the WEFS
Functioning Domain from the intake appointment to the second session, perhaps by
isolating the WEFS Positive Mental Health factors to determine whether a specific item
could predict a difference in scores from Time 1 to Time 2. Hope and optimism were
hypothesized as variables that could have mediated the relationship between functioning
scores. However, further assessment could lead to a better understanding in clinical
settings as to the components that encourage patients to return to their second session and
help with engagement in therapy.
A potential confound of the study may be experiential avoidance, as defined by
patients suppressing unwanted uncomfortable emotional or cognitive experiences.
Patients engaging in experiential avoidance may underreport their symptoms on the
WEFS, leading to inaccurate data. Future research may account for this potential
confound by also administering a measure of experiential avoidance. Future research may
also administer other standardized measures in each of the factors to further validate how
well the WEFS aligns in regard to convergent validity. Future research may include a
scale of social desirability as well to assess for an additional confound in which patients
could report based upon wanting to please their clinician.
Based on this preliminary study, the WEFS appears to be a promising measure
that could be applied in clinical practice. Overall, the general findings reveal that the
WEFS possesses sound psychometric properties related to reliability and validity. Further
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psychometric research is necessary to replicate the current findings and extend them.
Further research designed to investigate the stability of the intensity domain is warranted.
At this point, the WEFS may provide a useful, cost-effective, and efficient alternative to
employing numerous measures during intake and throughout treatment.
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